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ATTITUDES TOWARD THE HPV VACCINE AMONG UNIVERSITY STUDENTS: 
 











Background: In the United States, the Centers for Disease Control and Prevention (CDC) estimates that 
32,000 cancers occur annually that can be directly attributable to the acquisition of the Human Papilloma 
Virus (HPV). Gender specificity data posits that 21,000 of the annual cancer cases are female and the 
remaining 11,000 cases occur among males. However, because the implementation and trajectory of HPV 
vaccination and prevention programs have been historically aimed toward women, vaccination rates for 
men remain significantly lower. The purpose of this study was to assess how gender differences in 
knowledge attitude, subjective norms and perceived behavioral control about HPV and the intention to be 
vaccinated among a sample of university students. The Theory of Planned Behavior was employed as the 
theoretical framework for the study. Methods: a stratified proportional random sample of students 
attending one university with multiple campuses was utilized to collect data. Each campus site constituted 
a stratum, with two or more classes of an undergraduate level randomly selected from each campus. 
Results: A total of 383 usable surveys were obtained, which is consistent with obtaining a final sample 
size of 380 based on the power analysis of p≤0.05. A response rate of 84% was obtained which included 
face to face and on-line administrations. Overall results indicate a significant difference in male and 
female vaccination rates with females 1.945 times (1.450, 2.607) more likely to have been vaccinated 
against HPV than males (received all three doses);  Males were less knowledgeable than females on 
specific facts about HPV and the vaccination; were less likely to be influenced by family or peers to 
receive the vaccination and less likely to perceive their ability (perceived behavioral control) to obtain the 
HPV vaccine as high. Best practices for health education emphasize skill acquisition however, the results 
of this study suggest university health education programs need to include a strong knowledge component 
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The human papillomavirus (HPV) is the most common sexually transmitted infection 
affecting both males and females worldwide. In the United States alone, the Centers for Disease 
Control and Prevention (CDC) estimate that 44,000 cancers are directly attributable to the 
acquisition of HPV occurring annually (CDC, 2019). Gender specificity data posits that 25,000 
of the annual cancer cases are female with the remaining 19,000 cases occurring among males 
(CDC, 2019). Empirical evidence indicates that HPV infection is the cause of nearly all cervical 
cancers worldwide; however, emerging data suggests that acquiring an oral HPV infection is a 
catalyst to the acquisition of a subset of oropharyngeal cancers as well (Levesque, 2011). 
 
Oral HPV is more common in men than women (CDC, 2017), with the incidence among 
males of oral HPV acquisition approximately three times higher than in females (Levesque, 
2011). In the past, most incidences of throat and mouth cancers were primarily attributed to 
tobacco and alcohol abuse and most of these cancers occurred among men between the ages of 60 
and 80, were difficult to treat, and had high mortality rates. However, recent data suggest that 
about 70% of all oropharyngeal, head and neck cancer acquisition is primarily attributable to oral 
HPV infections, with HPV type 16 causing 60% of all oropharyngeal cancers (CDC, 2019). 
 
Although the link between oral HPV infection among men and oropharyngeal cancer has 
been wholly under-researched, the etiologic role of oral HPV infection in oropharynx cancer has 
been recently established. In the United States, oral HPV infection is directly linked to the 
majority of oropharynx cancer among men, and the total number of cases is expected to surpass 
the number of cervical cancers by the year 2025, if the current trend of increasing trajectory of 




Because HPV replicates well in a warm, moist environment, the incidence of penile and 
anal cancer can also be attributable to prolonged infection with the virus in men (CDC, 2016). 
Cancer of the penis and anus occurs similarly to cancer of the cervix; if an infection of HPV is 
untreated in some people with persistent high-risk HPV infections, the virus damages the cells' 
DNA and causes them to start dividing and growing out of control. Although the incidence of 
cervical cancer in under-developed countries far exceeds penile and anal cancer rates, in the 
United States, the number of HPV related cancer rates in men, including penile, oral, and anal 
cancer is increasing and is becoming comparable to the rates of cervical cancer in women (CDC, 
2016). 
 
Historically, the responsibility for contraception and prevention of sexually transmitted 
infections (STIs) have largely fallen on women (Daley, 2017). In 2006, Gardasil, also known as 
Silgard or recombinant human papilloma vaccine, was introduced as a revolutionary breakthrough 
vaccine to prevent the occurrence of cervical cancer caused by HPV infection. The vaccine 
specifically targeted the strains of Human Papillomavirus (HPV types 16 and 18) that were 
identified through viral typing to be responsible for cervical cancer; (Harper, et.al., 2010). 
Following the approval of the Gardasil vaccine, Merck Pharmaceuticals, the vaccine’s creator, 
funded a multimedia national campaign in the United States to educate the public on the 
relationship between HPV infection and cervical cancer. Merck emphasized the vaccine’s 
effectiveness against cervical cancer development to women through media campaigns, even 
though both men and women contribute inextricably to the spread of HPV and HPV related 
cancers (Harper, et al., 2010). 
 
In the United States, the HPV vaccination is recommended for adolescents ages 11 to 
12, with catch-up vaccinations recommended through age 26. Two doses of vaccine, given 6 to 12 
months apart, are recommended if the series is started before age 15. Three doses, to be completed 
within 6 months, are recommended for those who started vaccination at age 15 or older (CDC, 
2019). In 2019, the CDC reported that 21.5% of all young adults received the recommended 




recommended number of doses of the HPV vaccine was 35.3% and the percentage of men was 
9.0% (CDC, 2019). 
 
The developmental and implementation trajectory of the HPV vaccine since its 
introduction, targeted at women, (especially young adolescent women), is suggested to have 
created a gender bias. This artificial perception that males are not susceptible to acquiring HPV, 
and therefore bear no responsibility in preventing its spread, has resulted in significantly lower 
vaccination rates for males, thus increasing morbidity and mortality rates (Daley, 2017). 
Repeated targeting of the vaccine toward women has impeded male awareness of their 
vulnerability to the consequences of an HPV infection. As a result, the HPV vaccination 
awareness campaign has led to the social construction of HPV and cervical cancer as a “women-
only problem”. This has led to the feminization of the HPV and ultimately may be responsible for 
a lower vaccine trajectory for males. 
 
Resulting gender biases have negative implications for stakeholders in public health as 
well. The incidence of anal cancer in HPV positive men is quickly becoming comparable to the 
incidence of cervical cancer, with at least 90% of all anal cancers attributed to prolonged HPV 
infection (Hu, 2014). As a result, the economic burden associated with non-cervical HPV-related 
cancers occurring in individuals living in the United States was approximately $418 million in 
2014 (Hu, 2014). The social awareness campaign directed toward the female population has led 
to the social construction of and ultimately the feminization that HPV infection is a “women-only 
problem”. It has been suggested that this has contributed to a lower vaccine trajectory for males 
(Daley, 2017). 
 
Purpose of the Study 
 
The purpose of this study was to assess whether gender differences existed in 
knowledge, attitudes, beliefs, subjective influences and perceived behavioral control about HPV, 




This study sought to understand whether lack of awareness about the consequences of 
HPV (including knowledge, attitudes, effect of peer social norms) would predict lower intention 
to obtain the HPV vaccine specifically for males. It was important to include females in the study 
to compare whether there was higher knowledge, more positive attitudes and higher influence of 
peer social norms that would validate whether the lower vaccine trajectory in male in college 
students is a result of less awareness of the efficacy of the vaccine for preventing HPV. 
 
The Theory of Planned Behavior was selected as the theoretical framework to address the 
purpose of the study because the constructs of the model that examine attitudes toward a 
behavior, influences on attitude such as subjective norms and perceived behavioral control (the 
belief in one’s ability to perform a behavior) on behavioral intention. In the present study, the 
intent to behave was measured by the the number of “yes” responses to obtain the HPV vaccine. 
The current study is comparable to a study performed by Fisher, et al. (2016) in that intention 
was studied as a key determinant for whether or not college students were vaccinated against 
HPV. Statement of the Problem 
 
Although the Human Papillomavirus (HPV) vaccine has the potential to prevent mortality 
and morbidity from male reproductive organ cancers, the implementation trajectory of the 
vaccination has focused on females, potentially creating gender biases about HPV prevention 
through obtaining the HPV vaccine. 
 
The theoretical framework used to guide the current study was the Theory of Planned 
Behavior (TPB) (1991).The Theory of Planned Behavior (TPB) is a behavioral theory that is used to 
predict behaviors across a wide variety of domains, including health behaviors such as vaccine uptake 
(Glanz, 2011). TPB was developed by Icek Ajzen (1985) as an extension of the Theory of Reasoned 
Action (TRA) which posits that the most important determinant of behavior is behavioral intention 
(Ajzen & Fishbein, 1980). TPB adds an additional dimension of perceived control over a behavior. The 
TRA and TPB further assert that direct determinants of an individual’s behavioral intention are 




concerning a behavior (Ajzen & Fishbein, 1980). Other studies that used the TPB with 
college populations will be examined as well as studies that specifically used TPB to examine 
HPV knowledge and intention to be vaccinated. 
 
The constructs of the theory and their specificity to HPV vaccine uptake are listed below: 
 
1. Behavioral Intention: The motivational factors that influence behavior or, in other words, the 
intentions to obtain the HPV vaccine. The stronger the intentions of the individual to get 
vaccinated, the more likely they will do so. 
 
2. Attitude Toward a Behavior: The extent in which a person will have a favorable or 
unfavorable outcome about HPV vaccine uptake. A person’s attitude, in this case, consists of 
behavioral beliefs that obtaining the HPV vaccine would prevent him from acquiring HPV and 
developing cancer. 
 
3. Subjective Norm: Social pressure to perform a behavior or not. In the case of HPV 
vaccination uptake among males, the ideology of the feminization of the Human Papilloma 
Virus as a barrier to vaccination uptake among males will be assessed. 
 
4. Perceived Behavioral Control: Refers to perception of the ease or difficulty of obtaining 






1. Is there a difference in knowledge about HPV between male and female college students? 
 
2. Is there a difference in attitude between males and females toward obtaining the HPV vaccine? 
 
3. Is there a difference in influence of others between males and females toward obtaining the HPV 
vaccine? 
 
4. Is there a difference between males and females on their perceived behavioral control to 
receive the HPV vaccine? 
 






The study will be delimited to students attending a university with multiple campuses in 
Southeast Georgia. The study will be conducted during one semester. The surveys will be 
completed during class time in the presence of peers, therefore, there is a risk of response bias 
due to self-reporting. The study may not be indicative of attitudes and intentions regarding HPV 
of the entire college student population in Southeast Georgia due to difference in the location of 
the two campuses that will provide the sample. One campus is rural and the other urban which 
may demonstrate differences in attitude and intentions regarding HPV. It will be assumed by the 
researcher that all students completing the survey understood all questions and answered 
honestly about sexual activities and beliefs about HPV and HPV testing. 
 
Definition of Terms 
 
HPV- (human papillomavirus) is a virus that can cause certain cancers and diseases in both 
males and females. 
 
Gardasil- (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect girls and boys 
ages 9 to 26 against cervical, vaginal, vulvar, and anal cancers and genital warts caused by nine 
types of HPV. 
 
Feminization of a health issue-The strong social and cultural perception of a health topic as 
a “women’s only” issue. 
 
Gender Bias-unfair difference in the treatment of men or women because of their sex . 
 
Cervical cancer-A type of cancer that occurs in the cells of the cervix (the lower part of the 
uterus that connects to the vagina). 
 
Theory of Planned Behavior-The Theory of Planned behavior is a theory-based framework for 
understanding the multifaceted and interactive effects of personal and environmental factors that 
determine behaviors, and for identifying behavioral and organizational leverage points and 






Significance of the Study 
 
The study replicated previous studies using the TPB to understand barriers to obtaining 
the vaccine that prevents HPV among both male and female university students. By conducting 
research on the knowledge, attitudes, and perceived behavioral control toward HPV and HPV 
vaccinations among male college students, health educators will gain insight into perceived 
barriers to vaccination in this population. Findings from the study will assist health education and 
promotion efforts on college campuses by developing educational strategies that address barriers to 
students to obtaining the HPV vaccine. 
 
Chapter 1 Summary 
 
The purpose of this study is to assess knowledge and attitudes toward the HPV 
vaccination and their influence to serve as a barrier to HPV vaccine acquisition among a sample 
of university students. In Chapter 2, a literature review will be presented including a historical 
perspective of cervical cancer and the introduction of Gardasil. The studies reviewed also include 
research on the feminization of HPV and HPV related cancers. Chapter 3 contains methodology 
used to accomplish the purpose of the study. The results of the study will be discussed in Chapter 
 
4. Chapter 5 will contain a discussion of the results, conclusions drawn as a result of the study, 






REVIEW OF LITERATURE 
 
The purpose of this study was to assess gender differences in knowledge and attitudes 
about HPV and how these constructs influence the intention to be vaccinated among a sample of 
university students. 
 
This chapter reviews literature on the Human Papilloma Virus (what it is, how it is 
transmitted), differences of HPV prevalence in males and females, male reproductive cancers that 
result from HPV infection, a brief history of cervical cancer, studies addressing use of Gardasil, 
the vaccine available to prevent HPV, studies addressing gender bias in promoting the vaccine 
primarily to women, leading to the feminization of HPV and the vaccine, which may have 
impacted vaccine uptake, and studies examining sexual behavior that have used the Theory of 
Planned Behavior to explain vaccine uptake in adolescents and young adults. 
 
What is Human Papillomavirus (HPV) and How it is Transmitted? 
 
The clinical definition of HPV states that it is a virus that can cause abnormal tissue 
growth and other changes to cells in humans (CDC, 2017). More than 40 types of the virus are 
spread by sexual contact from the skin, mucous membranes of an infected individual to the skin, 
and mucous membranes of their sexual partners. Any individual who is sexually active can be 
exposed to HPV through skin or membrane contact of the mouth and throat, anus, vulva, or penis 
(CDC, 2017). This makes HPV particularly dangerous as it can be spread even in the context of 
what are traditionally considered “safe sex” behaviors, such as using condoms or engaging in 
outercourse (CDC, 2017). 
 
Over 150 types of HPV viruses, ten have been identified as oncogenic (CDC 2016). 
From these 150, at least 40 are spread through sexual contact (Cutts, 2007). The acquisition of 
HPV is common; most sexually active individuals in the United States are infected with HPV at 
some point. About 90% of the individuals infected with HPV do not present with any clinical 




infections can progress for years and, if left untreated, can lead to the development of 
cancer (Cutts, 2007). 
 
In 2010, the Human Papillomaviruses (HPV) were the most common cause of 
reproductive tract cancers which includes, penile, anal and vulvar cancers (CDC, 2011). HPV has 
also been linked to oropharyngeal cancers for both men and women. Thought to be the most 
prevalent type of sexually transmitted disease in the United States, most HPV infections do not 
lead to cancer. The CDC estimates that the prevalence of genital infection with any HPV type 
annually is 42.5% among United States adults aged 18–69 (CDC, 2014). Most of these infections 
are asymptomatic and appear to resolve spontaneously within a few years. However, almost of 
all cervical and anal cancers are caused by exposure to HPV (CDC, 2014). 
 
HPV can be categorized into two groups: low-risk HPVs and high-risk HPVs. Low-
risk HPVs can cause condylomata acuminate, or skin warts, but do not cause cancer. Two low-
risk HPVs, types 6 and 11, can also cause recurrent respiratory papillomatosis, a less common 
disease in which benign tumors grow in the air passages leading from the nose and mouth into 
the lungs (CDC, 2017). 
 
Two types of HPVs that are oncogenic and specifically related to the development of 
cervical cancer are types 16 and type 18 are also known as High Risk HPVs. (Thompson, 2014). 
The spread of HPV occurs through contact with infected skin of the genitals, mucous membranes, 
and bodily fluids. The virus lives in the body’s epithelial cells located on the skin’s surface, as 
well as on the surface of the vagina, mouth, anus, cervix, penis, and the back of the throat 
(Thompson, 2014). The World Health Organization (WHO), states that early infections of HPV 
can be detected by slight changes in the epithelium that are discovered by using virologic and 
cytological techniques screening (WHO, 2014). 
 
History of Cervical Cancer Detection 
 
In 1941, Georgios Papanicolaou, a Greek gynecologist in collaboration with Herbert 




smears could be completed. As a result, they determined that cervical cancer could be detected by 
inspecting cervical cells (Harper, 2010). The test was named the Pap smear after Papanicolaou. 
This revolutionary breakthrough in women’s health was enthusiastically adopted by gynecologists 
for use with their female patients. As a result, the cervical cancer rate in the United States dropped 
to about half of what it was at the turn of the century. In terms of precancers and early cancers 
detected, it remains the most successful screening test ever introduced for preventing serious 
malignancies. Since the 1950s, mortality rates for cervical cancer have fallen approximately by 
60%. However, it would be another forty years before the correlation between HPV and cervical 
cancer was established (Harper, 2010). 
 
For decades, the epidemiological profile of women with cervical cancer was recognized as a 
direct result of a sexually transmitted process, and several infectious agents were proposed over the 
years as a catalyst to cervical cancer: syphilis, gonorrhea, and type 2 herpes simplex virus (Bosch, 
2002). In a recent article, the researchers stated that the persistence of a genital infection generated by 
high-risk oncogenic HPV in cervical cells induces precancerous cervical lesions, 
 
regardless if women have normal immune systems or not (Anouar et al., 2020). Another recent 
study posited that certain genotypes of HPV are not only the necessary cause of cervical 
cancer, they are also the etiological cause of some anogenital and head and neck carcinomas 
(Guimera, Alemany, Bruni, & Muñoz, 2020). 
 
The story of Henrietta Lacks, a young Black woman who was diagnosed with cervical cancer 
in 1951, drew attention to the quick progression of late diagnosed cervical cancer. At the time of Mrs. 
Lacks’s diagnosis, the etiological correlation between HPV infection and cervical cancer had not yet 
been established. However, the cells that were removed from Mrs. Lacks’s biopsy of the tumor found 
in her cervix would be instrumental to the discovery that HPV was the oncogenic agent in almost all 
cervical cancer cases worldwide (Bosch, 2002). In fact, the cells labeled HeLa (the first two initials of 
her first and last name) became the first human cell line that was successfully grown in culture 




been in continual use in labs around the world for 65 years and has been instrumental for disease 
eradication and the production of vaccinations (Bustamam, 2017). 
 
Heralded as the first ever identified “necessary cause” of a human cancer, the correlation 
between HPV infection and cancer was thought to be as important as the association between 
smoking and lung cancer that was proposed by Harald zur Hausen, a German virologist and 
professor (Bustamam, 2017). In other words, the concept of a cause and a consequence (cervical 
cancer) implies that cervical cancer does not, and will not, develop in the absence of the persistent 
presence of HPV. In the early 1990s, the International Biological Study on Cervical Cancer group 
was set up to look at cervical cancer cases worldwide. After obtaining samples from women 
diagnosed with cancer in 22 countries, HPV was found in at least nine out of every ten cervical 
cancer samples, and this figure was consistent across the globe (Bustamam, 2017). In the study by 
Anouar Tadlaoui, et. al., it was also established that two types of the HPV virus (HPV16 and 
HPV18) was found in 82% of the cervical cancer cases as causative agents (Anouar 
Tadlaoui.et.al., 2020). 
 
Following the discovery in the 1980s by Harald zur Hausen that most cervical cancer 
cases were caused by prolonged HPV infection, researchers at the National Cancer Institute 
discovered that the proteins that form the outer shell of HPV could form particles that closely 
resemble the original virus and create high levels of potentially protective antibodies. The particles 
were not infectious, because they lacked the necessary viral genes. The virus-like particles 
subsequently became the basis for Gardasil, a new vaccine that was in development (Bustamam, 
2017). In recent times, the virus-like particles that are based on L1 proteins have been considered 
as the best candidate for vaccine development against HPV infections (Namvar, Bolhassani, Javadi, 
& Noormohammadi, 2019). 
 
The Introduction of Gardasil 
 
Introduced and licensed by the United States on June 8, 2006, Gardasil was a new vaccine 




cancer (Lexchin, 2010). According to the CDC, the Food and Drug Administration (FDA) first 
approved first-generation Gardasil, which prevented infection of four strains of HPV: 6, 11, 16, and 
 
18. In December 2014, Gardasil9 was approved by the FDA. This vaccine protects against 9 strains of 
HPV: the four strains approved in the previous Gardasil vaccine, as well as 31, 33, 45, 52, and 
 
58. The FDA recommended the vaccine for girls aged 9–13 years, or before the onset of sexual 
intercourse, and women aged 14–26, even if they had previous abnormal Pap smears or HPV 
infections (Lexchin, 2010). Uptake of the Gardasil vaccine consists of a three dose, quadrivalent 
process. The vaccine is currently approved in 123 countries, is prophylactic and contains virus-
like particles of HPV types that stimulate type-specific neutralizing antibodies (CDC, 2011). 
 
A systematic review was performed by Rambout and colleagues to test the efficacy of the 
vaccine among women aged 15-25 years not previously infected with vaccine-type HPV strains. 
Because HPV is known as the necessary cause for cervical cancers and prophylactic HPV vaccines 
are designed to prevent genital warts, precancerous cervical lesions and cervical cancer, the 
researchers wanted to gauge the potential impact of vaccine uptake on disease burden in the United 
States. The researchers conducted a systematic search of literature obtained through an online 
database search to identify all randomized controlled trials of prophylactic HPV vaccination 
between 2006 and 2007. Findings from the systematic review showed that prophylactic HPV 
vaccination was associated with a reduction in the frequency of high-grade cervical lesions caused 
by vaccine-type HPV strains when compared with control groups. It was concluded that the 
efficaciousness of the vaccine appeared to be high, and the incidence of adverse effects from the 
vaccine were low (Rambout, 2007). 
 
Markowitz, et.al., (2013) examined HPV vaccine uptake comparing data from the time the 
vaccine was introduced (2007-2010) with data collected in the pre-vaccine era (2003-2006) in a 
National Health and Nutrition Examination Survey (NHANES). NHANES reported that in a group of 
females between the ages of 14-19, only 34% were vaccinated during 2007-2010, an 11.6% decrease in 




However, the type of HPV prevalence that are covered by vaccinations decreased by approximately 
56%, a phenomenon that was examined by the researchers in the study (Markowitz, 2013) 
 
Because there were no mitigating factors such as changes in sexual behavior among the 
participants, the researchers suggested that an early uptake impact of the vaccination could be the 
reason behind low HPV prevalence among this age group due to herd immunity, vaccine 
effectiveness of a series involving <3 doses, and/or changes in sexual behavior that was not 
measured (Markowitz, 2013). However, because the data was self-reported, under or over reporting 
could have skewed results in the study. Considering the substantial health and economic burden of 
HPV associated diseases, this study is encouraging in that it reinforces the effectiveness of the 
vaccine (Markowitz, 2013) 
 
The Human Papillomavirus Infection in Men 
 
There is empirical evidence that male HPV infection contributes significantly to the 
transmission of the virus in women which subsequently can lead to cervical cancer. In a case-
controlled study of women with cervical cancer by Giuliano, et. al., it was established that a 
woman’s husband’s sexual behavior affects her risk of cervical neoplasia, even when controlling 
for female sexual activity (Giuliano, 2008). More recently, however, researchers have ascertained 
that HPV contributes to men's burden of diseases such as anal, penile, and oropharyngeal cancers. 
Many men are unaware of the HPV related cancers that are exclusively developed as a direct 
result from a prolonged infection with the Human Papilloma Virus (Daily, 2017). 
 
Along with penile, anal, and oropharyngeal cancers, there are other HPV related diseases 
such as condylomata acuminata (genital warts) and recurrent respiratory papillomatosi that are of 
clinical significanc to men. It is important to note that per Giuliano, an HPV infection in men may 
increase the risk of acquiring human immunodeficiency virus (HIV) infection as well, because 





Per Giuliano, it was noted that while relatively little is known about the epidemiology of 
HPV infection in heterosexual men, an understanding of HPV infection and associated disease in 
these men has assumed increasing importance because the efficaciousness of the vaccine Gardasil 
(Giuliano, 2008). It has been proven to be highly effective in preventing HPV types 6, 11, 16 and 
18 which most frequently affect men. However, despite the vaccine’s availability for men, only a 
few countries have implemented vaccination programs for men. In 2013, Australia became the 
first country to initiate government funded universal HPV vaccination programs for boys and 
began including boys in a national school-based HPV vaccination uptake (Newman, et. al, 2014). 
As Giuliano points out, lack of knowledge about the transmission of HPV, as well as the severity 
of the types of subsequent cancers specific to men, can be the catalyst to low male vaccination 
uptake and implementation of HPV vaccination programs for boys (Giuliano, 2008). A study by 
Pitts, et.al., (2017) also pointed out that the lack of males’ knowledge about their role in the spread 
of HPV, as well as lack of awareness about the HPV vaccination continue to be significant barriers 
to males receiving the vaccination. 
 
The cost-effectiveness of HPV vaccination in males 
 
While research has established a strong causal link between specific types of HPV infection 
and cervical cancer, fewer studies have been conducted on HPV infection in male reproductive organ 
cancers. Yet, the incidence of anal cancer in HPV positive men is quickly becoming comparable to the 
incidence of cervical cancer, with at least 90% of all anal cancers being a direct result of prolonged 
HPV infection (Hu, 2014). According to the Centers for Disease Control and Prevention (CDC) in 
2019, about 6,810 men were diagnosed with anal cancer and about 91% of those cancers were thought 
to be caused by HPV. The resulting economic burden associated with non-cervical HPV-related 
cancers occurring in individuals living in the United States was approximately $418 million in 2014 
(Hu, 2014). In another study by Wu, et.al., in 2018, it was found that the first two year per patient 
adjusted mean cost associated with anal cancer treatment was $127,531. Interestingly, because most 




conditions have focused primarily on cervical cancer, there are substantially fewer costing 
studies of noncervical HPV associated sequelae, or male cancer development (Hu, 2014). 
 
In 2013, there were approximately 500,000 new cases of anogenital warts reported to the 
Centers for Disease Control and Prevention (CDC) (CDC, 2015). In a study conducted by the CDC 
the researchers sought published estimates of the cost per episode of newly diagnosed genital warts 
because a single episode of anogenital warts is often associated with the use of a combination of 
different therapies, and there is wide variation in cost among the different treatment options. A 
study conducted during the introduction of the HPV vaccination found that women enrolled in a 
United States health care plan estimated that an average of $26,415 per 1000 women was spent on 
annual cervical screening and treatment for HPV-related diseases (Soper, 2006). In 2019, according 
to the CDC, about $1 billion was reported for cancer related treatments, including $0.4 billion for 
cervical cancer and $0.3 billion for oropharyngeal cancer. Furthermore, the treatment for 
anogenital warts in 2019 was approximately $0.4 billion in the United States alone. Taking into 
consideration all the combined therapies, in the United States the estimated lifetime total medical 
cost of HPV infection for men and women ages 15–24 is $2.9 billion, which makes HPV the 
second most expensive STI after human immunodeficiency virus (HIV) (Soper, 2006). 
 
Penile and Anal Cancer 
 
The acquisition of anal cancer primarily caused by an HPV infection is comparable to that 
of HPV associated cervical cancers (Bennett, 2015). Because there is a similarity of the tissue of the 
anal canal, including a transformation zone that is bounded on each side by squamous and columnar 
epithelium, HPV induced carcinogenesis leading to cervical cancer is comparable to the process that 
leads to anal canal cancer (Levesque, 2011). About 91% of all anal squamous cell carcinoma cases in 
the United States can be directly attributed to HPV infections. There are approximately 693 women 
and 377 men diagnosed with HPV associated anal cancers each year (Bennett, 2015). Although anal 




residing in the United States is increasing and is expected to be the most commonly 
diagnosed anogenital HPV associated cancer in 2020 (Bennett, 2015). 
 
Penile cancer is a rare malignancy of the genitourinary tract, with 0.58 per 100,000 men 
in the United States affected by the disease. However, exposure to HPV has been detected in 
nearly one half of all cases of penile cancer (Fernandez, 2014). Because penile cancer is rare in the 
United States, it is wholly under-researched. However, it has been established that the disease is 
associated with high mortality and significant adverse effects after treatment. Because treatment of 
penile cancer often leads to genital disfigurement, psychological and emotional distress are 
common side effects. Depression and anxiety are common after-effects post-treatment as well 
(Fernandez, 2014). The Epidemiology of Oral HPV Transmission 
 
The findings by Sonawane, et.al, (2017) that oral HPV begins with sexual debut, 
supports the idea that the acquisition of oropharyngeal cancer is strongly associated with sexual 
behavior beginning at adolescence. Per Sonawane et.al., (2017) the transmission of oral HPV 
occurs after performing oral sex on infected genitals. The research is unclear as to whether oral 
HPV can be spread through deep kissing. Through a study performed on a couple who both 
presented with oral cancer, identical HPV strains were identified, supporting the hypothesis of oral 
HPV transmission between the couple (Sonawane et.al., (2017). It was further discovered that 
partners of women with cervical cancer have a higher incidence of oropharyngeal cancer than the 
general population, supporting the hypothesis that the transmission of HPV from the genital region 
of an infected woman is possible to a partner during oral sex (Sonawane, 2017). 
 
Because sexual behavior is strongly associated with oral HPV acquisition, Sonawane, 
et.al., sought to examine a link between adolescent sexual behavior and oral HPV. Most of the 
surveys the researchers conducted on a sample of teen-aged participants about adolescent sexual 
behavior, indicated that a significant proportion of the adolescents engaged in oral sex prior to 
vaginal intercourse, and perceived oral sex as less risky (Sonawane, 2017). The participants 




survey performed by the National Survey of Family Growth, 38.8% of males and 43.6% of 
females aged 15 to 19 years residing in the United States have performed oral sex. In addition, 
approximately 12% of males and 10% of females in this age group have had oral sex but not 
vaginal intercourse (Sonawane, 2017). 
 
The incidence of HPV positive oropharyngeal squamous cell carcinoma (OPSCC) is 
disproportionately higher among men residing in the United States in comparison to women 
(Sonawane, 2017). There are approximately 11 million men residing in the United States with 
OPSCC and 3.2 million women. Men also have a 5.4% greater probability of high-risk oral HPV 
infection than women. The incidence of high-risk oral HPV infection is exacerbated by men who 
smoke more than 20 cigarettes daily and are current marijuana users. There is also a higher 
prevalence rate among African American males and those who report 16 or more lifetime vaginal 
or oral sex partners (Sonawane, 2017). 
 
No data is available on the costs for anal cancer rates in the United States, however, the 
researchers used a comparable study for anal cancer conducted in Canada to ascertain the 
economic burden for anal cancer in the United States (Hu, 2014). There are approximately 693 
women and 377 men diagnosed with HPV associated anal cancers each year in the United States 
(Bennett, 2015). About 91% of all anal squamous cell carcinoma cases in the United States can be 
directly attributed to HPV infections. Because the rates for developing anal cancer are increasing at 
a rapid pace each year in the U.S., the study that was done in 2015 is not quite indicative of the 
actual economic burden in the United States for anal cancer. However, the researchers estimated 
the total lifetime cost of all HPV attributable incident cases of anal cancer occurring in 2015 to be 
$92 million with a range of $44 to $178 million (Hu, 2014). 
 
The cost estimates for penile cancer are of interest for the current study about barriers 
to male vaccination because the American Cancer Institute (ACI) estimates that there are at least 
2,120 new cases of cancer to the penis diagnosed annually, resulting in 360 deaths each year. 




costs related to penile cancer include a primary care physician visit, surgery, anesthesia, 
hospitalization, radiation, chemotherapy, and visits with a specialist (Hu, 2014). Reconstructive 
therapies were not addressed. Taking all the therapies combined into consideration, the cost of 
penile cancer per year in the United States is approximately $8.6 million (Hu, 2014). 
 
The results of the study of cost analysis by Hu prove that there is a substantial economic 
burden in the United States due to HPV acquisition and related cancers for males. However, the 
study did not take into consideration non-clinical costs to the public, such as transportation costs to 
healthcare facilities or the value of work time lost receiving health care. There is also the issue of 
HPV positive males transmitting the virus to females, subsequent disease acquisition and economic 
burden for females that was not addressed in this study as well. A study performed by Gargano, et. 
al. gave a more thorough statistical analysis of health outcomes for females who were exposed to 
HPV and were diagnosed with invasive cervical cancer. In 2012, there were over 500,000 new 
cases and 265,000 deaths attributable to cervical cancer. The study discussed other significant, non-
cervical health outcomes for females that had been exposed to HPV as well. The largest proportion 
of cancers for females directly attributable to exposure to HPV between 2009-2013 were anal 
cancers (about 90%), followed by vaginal cancers (about 75%), oropharyngeal cancers (about 
70%), vulvar cancers (about 70%), and penile cancers (about 60%) (Gargano, 2017). 
 
Vaccine Efficacy for Males 
 
It was not until 2011, that recommendations by the advisory Committee on Immunization 
Practices recommended routine vaccinations for males (Markowitz et al., 2013). There are two 
significant categories related to the importance of HPV vaccine uptake in men: reduction of 
disease burden for males and reduced transmission of the virus to women (Quinn, 2015). Because 
it has been empirically established that HPV is spread through sexual contact, vaccination of males 
has the advantage of reducing the risk of HPV transmission to sexual partners, as well as reducing 
the spread of HPV in the general population and ultimately, HPV related cancers for both men and 




Although the most common cause of mortality related to HPV is cervical cancer, the 
disease burden for HPV-related cancers for men is becoming significant. Anal cancer rates are 
rising due to an increase in HPV acquisition and have more than tripled since the 1970s. Although 
males who have sex with other males (MSMs) are at a higher risk for the development of anal 
cancer, the incidence of anal cancer in heterosexual men is increasing, with about 2% more cases 
diagnosed each year (Quinn, 2015). Because acquisition of HPV is directly responsible for the 
development of at least 90% of all anal cancers, HPV vaccine uptake among males is imperative to 
prevent HPV infection (Quinn, 2015). Despite eligibility to receive catch-up doses up to age 26 
years, low HPV vaccination rates leave a large population of college-aged males unprotected. 
 
The incidence of genital HPV infection among men is similar to that among women 
(Quinn, 2015). The transmission of HPV is common, and the median clearance time of infection is 
approximately six months. The peak rise of any HPV infection is approximately ten years from the 
first sexual experience for both men and women. There are at least 40 types of the more than 100 
types of HPV that have been identified that affect the genital tract; however, as in the case of 
cervical cancer for women, types 18 and 16 are the oncogenic types that cause nearly all anal, 
penile, and oropharyngeal cancers in men (Quinn, 2015). An article by Senkomago, et.al., (2019) 
stated that recently, it has been discovered that oncogenic HPV types 16, 18, 31, 33, 45, 52, and 58 
are causally attributable to nearly all cervical cancers and some cancers of the vagina, vulva, penis, 
anus, and oropharynx 
 
Long term infection for both men and women can cause both benign and malignant 
anogenital disease, as well as head and neck lesions (Quinn, 2015). However, in clinical trials, HPV 
vaccinations were safe and are 90% to 100% effective against persistent infection with HPV types 6 
and 11 and genital warts in women and men. Furthermore, although Gardasil uptake was first 
recommended for individuals between the ages of six and eleven, the Food and Drug Administration 
(FDA) approved a prophylactic quadrivalent HPV vaccine in 2006 for females between the ages of 9–




group. Individuals receiving the prophylactic quadrivalent vaccine found the vaccine efficacious in 
reducing more than 90% of external genital lesions and approximately 90% efficacious in 
preventing persistent infections caused by the HPV types covered in the vaccine, including the 
oncogenic types 16 and 18 (Quinn, 2015). This information is critical to the current study in that 
our sample contains college-aged individuals. 
 
Gender Norms Influential in Male Vaccine Uptake 
 
Prior to Gardasil being approved, Merck pharmaceuticals narrativized the vaccine as a 
women’s only health issue through awareness campaigns linking the vaccine to cervical cancer, 
even though medical research has ascertained the role of men in HPV transmission (Stanley, 
et.al., (2017). Misperceptions of men about their role in HPV acquisition and transmission 
disproportionately affects decisions concerning vaccine uptake, as well as causes gender 
discourse in responsibility for prevention in sexual matters (Stanley, 2017). 
 
In the book “The Vulnerable Empowered Woman: Feminism, Postfeminism, and 
 
Women’s Health,” Tasha Dubriwny discusses the dynamics of public discourse concerning HPV 
 
and public history of burdening women with the responsibilities of providing preventative 
 
measures regarding STIs and pregnancy (Dubriwny, 2012). Dubriwny agrees with Stanley in that 
 
the initial trajectory of the Gardasil vaccination aimed at eradicating cervical cancer, further 
 
ingrained the notion of HPV prevention as a “women’s only issue,” even though the nature of the 
 
commercials were supposed to empower women. Even the inclusion of young men into HPV 
 
vaccination campaigns would have little or no effect on public discourse about the overall message 
 
concerning HPV and sexuality according to Dubriwny. The idea that women will not be thought of 
 
as having high moral standards if they contract a sexually transmitted disease such as HPV has 
 
historically been considered a social norm. Even if they lessen their chances by becoming 
 
vaccinated, their reputations are still at the mercy of their “risky” sexual behavior and the 
 




Stanley (2017) discusses the constructs of the self-categorization theory; particularly, the 
social shift of social identity that is built on contrasting one’s ingroup with a relevant outgroup 
and its meaningful consequences for group member’s perceptions, attitudes, and behaviors. In the 
case of HPV prevention and vaccine uptake, men adhere to perceived social perceptions and 
norms concerning responsibility of sexual issues, simply because men value gender as a social 
identity more than women do, as reflected in stereotypical gender norms pertaining to masculinity 
and public health issues (Stanley, 2017). Men who adopt a stronger, traditional role of 
masculinity, and who perceive other men of not engaging in health promoting behavior, typically 
perform fewer healthy behaviors themselves (Stanley, 2017). 
 
Low male HPV vaccination uptake illustrates the influence of gender discourses and 
norms, as well as identifies concerns that males may have about emasculation towards vaccine 
uptake (Stanley, 2017). Misperceptions among males who recognize HPV vaccination uptake as 
a women’s issue can cause them to reject inquiring about HPV and other feminized sexual health 
issues with their healthcare provider. Male perceived denial of vulnerability, compounded by the 
fact that more women seek medical advice than men, can create provider bias and consequently, 
healthcare provider preference for vaccinating women (Stanley, 2017). 
 
Even though discourse identifies women as the most vulnerable when it comes to 
negative outcomes of sexual activity, most college men envision an ideology that women and men 
are equal concerning sexual health (Stanley, 2017). However, most men recognize that, 
realistically, women are more responsible, even though most men agree that men are more 
sexually active and engage in higher risk sexual activities. Perceived knowledge about sexual 
health was cited in Stanley’s study as well. Most men believed that women have a greater access to 
sexual knowledge through their mothers, and that fathers felt too much discomfort to discuss 
sensitive sexual material with their sons. Because there are discrepancies in the parental 
knowledge afforded to sons and daughters, resulting normative referents among male peers dictate 




Intentions of Men to Receive the HPV Vaccine 
 
While the incidence for cervical cancer has decreased, the incidence of HPV positive 
anal cancer has been rising in men who have not participated in vaccine uptake (Gilbert, 2010). 
Because the early marketing of Gardasil specifically targeted females, gender bias toward HPV and 
HPV related cancers has become the perceived norm, causing the “feminization” of HPV (Daley, 
2017). Even though clinical trials of Gardasil indicate that the vaccine can significantly prevent 
anal cell changes acquired by prolonged HPV infections, the perceived feminization of HPV and 
HPV related cancers could cause lower vaccination rates for men when compared to women 
(Gilbert, 2010). 
 
In a study performed with a university sample by Gilbert, et.al., a comparison was made 
between heterosexual and gay men toward receiving an HPV vaccine. The authors sought to glean 
information about HPV vaccine awareness, knowledge, and attitudes in comparable samples of 
heterosexual and gay men. The researchers had hypothesized that most of the male participants 
would not have heard of HPV or related cancers for men (Gilbert, 2010). As expected, most of the 
participants had not heard of male roles in the spread of HPV, and most males were unaware of a 
vaccine for the prevention of HPV (Gilbert, 2010). These findings further corroborate our 
hypothesis that knowledge among males about HPV and related cancers is limited. 
 
After extensive exposure to information about HPV and related cancers among men, 
receptiveness of the vaccine varied substantially among the groups examined; 94% of gay males 
who had significant exposure to HPV related information through the study intended to vaccinate 
against HPV, regardless of whether a safe and effective vaccine was available, compared to 62% 
of heterosexual university males who were willing to consider HPV vaccination (Gilbert, 2010). 
Our hypothesis about negative attitudes towards HPV vaccination among heterosexual males 




Gender Bias and HPV Infection 
 
Gender bias towards HPV acquisition is exacerbated by the fact that there is not a 
screening test for HPV available for men; there is only a visual inspection for clinicians to check 
for lesions or warts on males (Daley, 2017). There is no specific way to test directly for HPV in 
men that is approved for clinical use. The only approved tests on the market for primary, 
preventative care for HPV are for screening women for cervical cancer, which further reinforces 
the ideology that women are responsible for HPV prevention. Because females are burdened 
with both the primary and secondary prevention of HPV, males fail to receive adequate 
preventative measures of HPV acquisition; further increasing the likelihood of acquiring HPV 
related diseases (Daley, 2017). 
 
Males can suffer numerous consequences from gender bias that could mislead them about 
who is more likely to spread HPV. This type of bias, often referred to as the feminization of an 
issue, occurs when the social construction of the issue is directed toward females. Since the 
introduction of the HPV vaccine Gardasil, the implementation trajectory has been focused on the 
vaccine’s usefulness in preventing cervical cancer, even though the burden of HPV acquisition 
does not disproportionately affect one gender over the other (Daley, 2017). Direct and indirect 
gender biases and inequities for HPV vaccine uptake can be partially attributed to the specific focus 
of Gardasil manufacturers on females. 
 
In the case of HPV, the feminization of HPV and HPV related cancers was that if 
vaccination rates for HPV in females were adequate, herd immunity could be achieved, thus 
absolving males for HPV prevention responsibilities (Daley, 2017). However, HPV vaccination 
rates for females residing in the United States are nowhere near achieving herd immunity threshold. 
Furthermore, the herd immunity ideology does not take into consideration men who have sex with 
other men (MSM) (Daley, 2017). Per Daley, the sub-group of MSM does not receive enough 
protection from HPV, even though clinical trial data among MSM who have been vaccinated with 




subgroup has a higher rate of these types of cancers, missed opportunities for vaccine uptake among 
can result in increased morbidity and mortality among HPV positive MSM (Daley, 2017). 
 
The concept of gender bias occurring when the social constructs of an issue become 
feminized is not a new phenomenon. The historical concept of feminization can be traced back 
to the 1970s, when issues of equal pay for women, as well as complex social reconstruction 
issues such as women taking on new roles as breadwinners, has helped to shape the concept of 
gender bias (Daley, 2017). 
 
The transmission of the virus can debunk the idea of gender specificity of HPV and 
related cancers itself. HPV acquisition can only occur through sexual contact, which includes skin 
to skin contact, genital to skin contact, and oral to genital contact, implying that it is necessary for 
an individual to have contact with another person to acquire the virus (Daley, 2017). Furthermore, 
it is estimated that nearly 85% of women and 91% of men, with at least one sexual partner from 
the opposite sex, will contract HPV infection during their lifetime. It is estimated that more men 
acquire HPV through heterosexual transmission than women as well (Daley, 2017). 
 
The Theory of Planned Behavior Related to College Students and HPV Vaccination Rates The 
Theory of Planned Behavior (TPB) was chosen for this study because university 
 
students were studied to see if their decisions to be vaccinated or not against HPV was influenced 
by their knowledge about HPV, their attitudes toward HPV vaccination, their perceived 
behavioral control toward receiving the vaccine and their intention to do so. 
 
The Theory of Planned Behavior (TPB) has been used to predict behaviors across a wide 
variety of health behaviors (Glanz, 2011). TPB was developed by Icek Ajzen (1985) as an 
extension of the Theory of Reasoned Action (TRA) which hypothesizes that the most 
important determinant of behavior is behavioral intention based on an individual’s attitude and 
subjective norms toward a behavior (Ajzen & Fishbein, 1980). The additional dimension of 




A study performed in 2019 (Preston & Barrow) utilized the Theory of Planned Behavior 
(TBP) to examine differences in HPV related knowledge, attitudes, and practices among men and 
women attending college in south Florida. The researchers used the constructs of the TPB to 
make a direct correlation to vaccine uptake among males and knowledge and attitudes influencing 
positive intention toward receiving the vaccine (Preston & Barrow, 2019). 
 
After assessing knowledge about HPV and HPV vaccination, the study found that male 
participants were significantly less aware of HPV vaccine age recommendations than the female 
participants were. The researchers stated that low awareness about HPV vaccination could be 
because Florida public schools have adhered to an abstinence only or abstinence-based sexual 
health curriculum (Preston & Barrow, 2019). 
 
The study also examined differences in attitudes toward HPV vaccination among men 
and women. The study found that over 70% of men had not been vaccinated, and only 26% of 
women and 4% of men had received all three doses of HPV vaccine, despite men reporting similar 
knowledge about the vaccine as women (Preston & Barrow, 2019). The male participants with 
negative attitudes toward HPV vaccination were significantly less knowledgeable in comparison to 
their female counterparts about HPV and HPV vaccination and were less likely to have received 
the vaccine. This finding is consistent with other studies in which it was concluded that HPV 
knowledge is a predictor of favorable attitudes toward vaccination. 
 
In another study by Catalano, et. al., the TPB’s constructs were utilized to predict 
behavioral intentions of college-aged men toward receiving the HPV vaccination. The sample 
consisted of college men who were at least 18 years of age. Previous awareness and knowledge 
about HPV and HPV vaccination were reported as low by about one-third of the sample. 
Approximately one half of the respondents indicated that they had not heard of a vaccination 
against HPV until they participated in the study (Catalano, et. al., 2016). 
 
Most of the respondents in the study indicated that they had engaged in oral, vaginal, or anal 




because the researchers suggested that most college men have increases in their sexual contacts 
over the duration of their collegiate career, putting them further at risk for an exposure to an 
HPV infection (Catalano, et. al., 2019). 
 
Attitudes about HPV vaccinations were also assessed in the study by Catalano. The 
reported means scores were low, suggesting that the respondents had unfavorable attitudes 
about receiving the HPV vaccine series within the next 12 months. The researchers also found 
that attitude was a significant predictor in the respondents’ behavioral intention to receive all 
three doses of the HPV vaccination within the following year (Catalano, et. al., 2019). 
 
Subjective norm mean scores for the men in the study were reported as low, indicating 
that the participants did not perceive social pressure to be vaccinated against HPV. The researchers 
indicated that subjective norm was the strongest predictor of behavioral intention toward receiving 
the series of HPV vaccinations among the participants in the study (Catalano, et. al., 2019). 
 
Although the means scores were slightly low for perceived behavioral control, it was not 
a significant predictor toward the intention of males to receive the HPV vaccination. The 
researchers suggested, however, that because respondents lacked enough knowledge about HPV 
and the HPV vaccination process, they would not be able to make an adequate assessment about 
what the vaccination process would entail (Catalano, et. al., 2019). Inadequate knowledge about 
HPV and HPV vaccination was also a factor in low means scores for behavioral intention to 
receive the HPV vaccination among the respondents. This finding is consistent with other studies in 
which insufficient knowledge about HPV is directly correlated with low vaccination rates among 
males (Preston & Barrow, 2019). 
 
In a study performed by Johnson and Ogletree (2017), knowledge about HPV and 
behavioral intention toward HPV vaccination among college men was assessed. A little over half of 
the sample had not heard of HPV and 60% of the respondents indicated that they had not heard of 
HPV vaccinations for men prior to this study. Most of the participants reported that they had a 




significant predictor of the intention to be vaccinated. Both perceived behavioral control and 
subjective norms were found to be significant predictors of behavioral intention among the men 
to receive the HPV vaccination, however, subjective norms, or where the men received their 
information about HPV and HPV vaccinations, proved to be the strongest predictor of behavioral 




The purpose of this study was to assess whether gender differences existed in 
knowledge, attitudes, beliefs, subjective influences and perceived behavioral control about 
HPV, and the intention to obtain the HPV vaccine among a sample of university students. 
 
In Chapter 2, the literature on Human Papilloma Virus including differences of HPV 
prevalence, male and female reproductive cancers that result from HPV infection, studies 
addressing use of Gardisil (HPV vaccine), studies addressing gender bias in promoting the 
vaccine and studies examining sexual behavior that have used the Theory of Planned Behavior 
to explain vaccine uptake in adolescents and young adults was presented. 
 
Chapter 3 will contain the methodology used to accomplish the purpose of the study. 
The results of the study will be discussed in Chapter 4. Chapter 5 will contain a discussion of the 







RESEARCH DESIGN AND METHODS 
 
 
This chapter presents an overview of the research methodology utilized in this study. The 
setting of the study, research design, protection of human subjects, sample methodology, 





The purpose of this study was to assess knowledge and attitude about HPV, and 
how attitudes influence the intention among college students to be vaccinated among a 
sample of university students. 
 
The following research questions guided the study: 
 
1. Is there a difference in knowledge about HPV between male and female college students? 
 
2. Is there a difference in attitude between males and females toward obtaining the 
HPV vaccine? 
 
3. Is there a difference in the influence of others between males and females toward 
obtaining the HPV vaccine? 
 
4. Is there a difference between males and females on their perceived behavioral control to 
obtain the HPV vaccine? 
 
5. Is there a difference between males and females on their intentions to obtain the 
HPV vaccine? 
 
Setting of Study 
 
The study setting was on two campuses of Georgia Southern University (GSU) located in 
Southeastern Georgia. Georgia Southern University, Statesboro campus, is an institution with an 
enrollment of 20,418 students in 2017 (Georgia Southern University, 2017). The Armstrong 




2016). As of January 1, 2018, consolidated Georgia Southern University overall enrollment 
grew to approximately 27, 518 students. 
 
For the 2017-18 academic year, the Statesboro campus’s student body consisted of 43.7% 
males and 56.3% females, with the majority of students (94%) residents of Georgia while the 
remaining 6% came from out of state or international (Georgia Southern University, 2018). More 
than half (62%) of the students identify as Caucasian and 26% identify as African American 
(Georgia Southern University, 2018). For the same time period, the Armstrong campus body 
reported that 33.2% of students were male and 66.8% were female (Armstrong University, 2016). 
The majority of students (86%) of the students were from Georgia and 14% were from out of 
state or international. Almost 60% of the students self-identify as Caucasian and 25.5% self-
identify as African American (Armstrong University, 2016). The purpose of conducting the study 
on both campuses is that one campus is rural, and one campus site is urban. 
 
Study Design/Research Methodology 
 
The study employed a quantitative approach to data collection. Specifically, a quasi-
experimental, exploratory, cross-sectional research design in which data was collected. Rigorous 
quantitative sampling was employed. 
 
A stratified proportional random sample of students attending one university with 
multiple campuses was implemented. Each campus site constituted a stratum, with two or 
more classes of an undergraduate level randomly selected from each campus. Intact classes 
were identified. To obtain a final sample size of 380 participants based on the power analysis 
of p≤0.05, an initial sample of 450 students was sought (Creswell, 1997). Proportional 
sampling between stratum necessitated that the Statesboro campus have at least 337 
participants (74.8%) and Armstrong campus with 113 participants (25.2%) (Creswell, 1997). 
 
Originally, the study was to include qualitative components consisting of individual 




students. Due to low participation and the inability to reach saturation required for meaningful 




During the Spring 2018 semester, approximately 30 faculty members were contacted 
requesting permission to survey their classes. Out of the 30 contacted, 10 faculty members gave 
permission for in class surveys. During the initial contact timeframe, many faculty members 
indicated that their classes were online. Therefore, an electronic version of the survey was created 
via Qualtrics© and the link was shared with the online instructors. Fifteen faculty members were 
asked to share the online survey link with their classes; six faculty members granted permission 
to survey their classes face to face. Approval for the research study was received by the 
Institutional Review Board. Out of the 384 completed surveys, 95 were completed on-line; 
therefore, approximately 25% of the respondents completed the survey on-line and 75% 
completed the survey in person during the scheduled class time. (Appendix A). One 
questionnaire was excluded from analysis due to incompleteness (less than 20% of the survey 
completed), resulting in a sample size of 383. A survey was given face-to-face to the randomly 
selected classes of students. After contact was made with instructors requesting their permission 
to survey their classes over the summer, it was determined that many of the classes were online. 
This necessitated the creation of an online version of the survey instrument and an addendum to 
the IRB to reflect this additional mode of data collection. At the end of the survey instrument, 
participants indicated their willingness to participate in compensated interviews to complete the 
qualitative data collection. The researcher’s email address was provided for interested 




The sample for this study was undergraduate students who attend a mid-sized university in 
the Southeast portion of the United States. Individuals were eligible to participate in the study if they 




This study has met all criteria for the protection of human subjects and permission from 






The instrument consists of a modified 40-item questionnaire created from a previously 
established instrument (Caron, et.al., 2008 & Jasper, 2014). Content face validity was verified by 
committee members and previous substantiation while internal consistency was established by 
conducting a Cronbach’s alpha coefficient analysis which was reported as .69. The amount of 
time to complete the questionnaire and comments of the mechanics of the questionnaire were also 
recorded. Specific items were revised based on calculated results and participant feedback. Ten 
questions assessed the participants’ knowledge about HPV and HPV vaccination uptake with a 
closed choice response. Sample knowledge questions include: “How do you think HPV is 
spread?” and “Have you ever heard of Gardasil™, a vaccine to prevent cervical cancer that was 
approved by the FDA in June 2006?” Twelve questions assessed attitudes and beliefs toward the 
HPV vaccination. Sample questions included “It’s not safe to get the HPV vaccine shots” and 
“Getting vaccine shots against HPV would be a good way for males to protect their health.” Six 
questions assessed behavior related to transmission and contracting HPV. Sample of behavioral 
questions include: “What changes would you make if you found out that your partner has HPV?” 
and “Do you and your partner talk about STDs?” The next set of twelve items assessed perceived 
risk about the HPV vaccine and is presented on a Likert-type scale with responses ranging from 
strongly agree to strongly disagree. Sample perceived risk questions include: “It is not safe to get 
the HPV vaccine shots” and “HPV vaccine shots are dangerous.” At the end of the quantitative 
portion of the instrument, participants were asked about their willingness to be contacted to 
participate in a telephone interview. 
    39 
Figure 3.1    
Data Analysis and Procedures    
# Research Questions Variables Variable Statistical Test 
   Classification  
     
Items 1. Is there a difference in knowledge Knowledge Interval, Frequencies, 
1-10 about HPV between males and females? items Total Means, Standard 
  Gender knowledge Deviation 
  Year in School, score Cross Tabulation 
  Age of first  ANOVA 
  sexual   
  intercourse,   
  Ever   
  been   
  vaccinated   
     
Items 2. Is there a difference between males and Attitude items Interval, Frequencies, 
12-23 females in attitudes toward HPV and Gender, Year Total Means, Standard 
 obtaining the HPV vaccine? in School attitude score Deviation 
    ANOVA 
     
Items 3. Is there a difference between males and Subjective Interval, Frequencies, 
24-28 females on the influence of others toward Norms Total Means, 
 HPV vaccination? Gender, Year influence Standard 
  in School score Deviation 
    ANOVA 
     
Item 4. Is there a difference between males and Behavioral Nominal Frequencies, 
29-48 females in intention to obtain the HPV intention items Interval Logistic 
 vaccine? Gender  Regression 
  Year in School   
  Sexual Activity   






After all data was coded, frequencies were calculated for all items with additional 
comparative analyses performed for specific demographic characteristics and specific categorical 
variables. In order for reliable and valid measures of latent, theoretical constructs, the variables 
that are related to one another were used to compute composite, or total score (Creswell, 1997). A 
multiple-regression model assessed independent variables contribution to predict vaccination 
intention: age (continuous, in years), cumulative knowledge (as measured by the number of 
correct responses on the knowledge portion of the instrument), and attitudes towards HPV 
vaccination (*see Likert portions of instrument*). 
 
There were three primary outcomes of interest in this study: a) knowledge about HPV 
and the HPV vaccination, b) attitudes toward HPV infection and the HPV vaccine and c) 
perceived behavioral control concerning obtaining the HPV vaccine. All statistical analysis was 
performed using the software IBM SPSS Statistics 25(v.28) (IBM Corp. Released 2017). 
Summary 
The purpose of this study was to assess knowledge and attitudes about HPV and how 
attitudes influence the intention to be vaccinated among a sample of university students. In 
Chapter 2, a literature review was presented relating to the perceived risk, attitudes and behaviors 
of men concerning HPV vaccine uptake and related cancers. Chapter 3 contains the methodology 
used to accomplish the purpose of the study. The results of the study will be discussed in Chapter 
4. Chapter 5 contains a discussion of the results, conclusions drawn because of the study, and 








Chapter four presents the results of this study pertaining to the knowledge, attitudes, 
subjective norms, perceived behavioral control and intention of receiving the HPV vaccinations 
among college aged students. The Theory of Planned Behavior constructs guided the survey 
questions and framed the results of the study. 
 
The data will be presented in the following order: Demographic variables that describe 
the study sample, and the results of the study will be presented by research questions. Statistical 
analysis performed included frequencies, descriptive statistics, one-way analysis of variance 




Demographic data collected included questions pertaining to gender, race, major/college 
within the university, year in school, self-report of sexual activity, age of first sexual intercourse, 
current relationship status and general health status. The majority of the respondents were female 252 
(51.2%) and 131 (34.2%) were male. There were 51 respondents (14.6%) who did not respond to the 
question of gender. There were 216 (56.4%) who identified as White/Caucasian. The remaining 
respondents were broken down as follows: Black or African American, 118 (30.8%), 1 (.3%) 
respondent was American Indian or Alaskan Native, 7 (1.8%) respondents were Asian, 1 
 
(.3%) respondent identified as Native Hawaiian or Pacific Islander, 22 (5.7%) identified themselves 
as two or more races, and 14 (3.7%) respondents identified as other race. Four respondents did not 
report their race. With respect to year in school, the sample was comprised of 82 (21.4%) 
Freshmen, 49 (12.8%) Sophomores, 108 (28.2%) Juniors, and 119 (31.1%) Seniors. Table 4.1 





Descriptive Statistics of Demographic Variables of the Total Sample of College Students  
Variable Frequency (n) Percentage (%) 
Gender    
Female  196 51.2 
Male  131 34.2 
Race    
White/Caucasian  216 56.4 
Black or African American  118 30.8 
American Indian or Alaskan Native  1 .3 
Asian  7 1.8 
Native Hawaiian or Pacific Islander  1 .3 
Two or more races  22 5.7 
Other  14 3.7 
College    
Jiann-Ping Hsu College of Public Health 77 20.1 
College of Business Administration  41 10.7 
College of Behavioral and Social Sciences 22 5.7 
College of Arts and Humanities  62 16.2 
Waters College of Health Professions  35 9.1 
College of Education  81 21.9 
College of Science and Mathematics  12 3.1 
Other  50 13.1 
Year in School    
Freshman  82 21.4 
Sophomore  49 12.8 
Junior  108 28.2 
Senior  119 31.1 
 
Respondents were asked about whether they had ever been sexually active and their age 
 
of first sexual intercourse. For the current sample, 88% reported that they have had sexual 
 
intercourse (anal, oral or vaginal). For both male and female students in the sample, the mean age 
 
at first sexual intercourse was in the 16-18 year age category with responses ranging from age 11 to 
 
23. The mean number of sexual partners was 4.57 for female students (n=196) and 6.9 for male 
students (n=131). There were 55 students who did not respond to this question. Most of the 
respondents identified as being single, 111 (29.0%); with 66 (17.2%); 15 (3.9%) reported as being in a 
monogamous relationship; married and living with a partner and the same number not married but 




asked to report their general health status. More than half of the respondents reported their general 
 
health to be very good to excellent.  It would be expected that most college students in the age 
 
range of this sample would be in good health. There were three responses that were missing for 
 
this variable. Data for these variables are presented in Table 4.2. 
 
Table 4.2  
Frequencies for sexual activity, Age at first intercourse, and perception of overall health of the total 
sample of college students 
_________________________________________________________________________ 
  N % 
Sexually Active      
Yes 337 88.0 
No 36 9.4 
Sexually Active      
Females      
Yes 170 88.1 
No 23 11.0 
Males      
Yes 115 89.0 
No 13 10.2 
Age of First Sexual Intercourse      
11-12 3 .9 
13-15 50 14.2 
16-18 190 54.0 
19-22 80 22.7 
23+ 18 .8 
Health Status      
Excellent 72 18.8 
Very Good 138 36.0 
Good 97 25.3 
Fair 56 14.6 
Poor 17 4.4 
Ever been vaccinated      
Females      
Yes 115 59.0 
No 53 27.2 
Male      
Yes 37 30.0 
No 34 27.9  
 
 
Because HPV is primarily a sexually transmitted disease, the researcher was interested in 
 




A cross tabulation was performed for these variables. For the current sample of university 
students, those who were sexually active increased with year in school beginning in the sophomore 
year. It is interesting to note that in this study, more freshmen respondents reported being sexually 
active than sophomores. The results are presented in Table 4.3. 
 
Table 4.3  
Crosstabulation for Ever had sex by Year in school 
 
Year in School  Have you ever had sex?  
 No  Yes Total 
     
Freshman 9  66 75 
Sophomore 6  43 49 
Junior 10  96 106 
Senior 11  108 119 
     
Total 36  313 349 
     
 
 
Participants were asked if they had ever been vaccinated against HPV. There were three 
choices of answers: Yes, I have received all three doses of the vaccine, No I either never received any 
dosage OR I received partial dosage, and not sure. Answers were coded as one for yes, zero for no or 
partial and two for not sure. Comparison of male to female vaccination rates found that females were 
1.945 times (1.450, 2.607) more likely to have been vaccinated against HPV than males (received all 
three doses) (see Table 4.4). This is a significant finding (p<0.005). 
Table 4.4 
Odds Ratio Comparing Female to Male Vaccination Rates  
____________________________________________________________________________ 
Variable N OR 95% CI Chi Square 
____________________________________________________________________________  
Vaccinated  317 1.945* 1.450, 2.607 24.67 
 
 
The remaining results will be reported by the research questions. Questions 2-4 in 




Research Question 1 
 
Is there a difference in knowledge about HPV between male and female college students? Prior 
to the analysis of variables that align with the constructs of the Theory of Planned 
 
Behavior, a set of 10 questions (7 multiple response and 3 single response items) assessing the level 
of knowledge about HPV and the HPV vaccine were performed. For the single response questions, 
there was only one correct answer. Responses were coded as “0” for incorrect and “1” 
 
for correct. For the multiple response questions, each response was coded separately. A cross-
tabulation of knowledge questions by gender was run to compare percentages by demographic 
characteristics. The results are presented in Table 4.5 
 
Table 4.5 
Crosstabulation of knowledge questions by gender 
Variables Agree Disagree Agree Disagree Don’t  P value 
 Males Males Females Females know   
 % n % n % n % n %  n  
If you have ever heard of             
HPV, the symptoms of             
HPV include:             
Warts that sometimes itch or 68.0 89 32.0 42 60.3 139 29.7 57    P<0.05 
bleed             
Sores of the penis or vagina             
that don’t heal 53.4 70 46.6 61 55.6 109 44.4 87     
Discharge from genitals             
 50.3 66 49.7 65 45.9 106 54.1 90     
Warty growths 54.1 71 45.9 60 54.6 107 45.4 89     
Burning upon urination 50.4 66 49.6 65 50.0 98       
Reduction of urine flow 46.6 61 54.4 70 50.5 99 44.4 84     
No visible signs or             
symptoms 7.6 10 92.4 121 8.1 16 91.9 180     
Don’t know         1.1  4  
If untreated, HPV can             
Cervical cancer 87.8 115 12.2 16 75.5 148 24.5 48    P<0.05 
Infertility 78.6 103 21.4 28 69.4 136 30.6 60     
Pre-cancer 90.8 119 9.2 12 75.0 147 25.0 49     
Death 72.5 95 27.5 36 62.8 123 37.2 72     
Cause warts 89.3 117 10.7 14 75.0 147 25.0 49     
Will disappear 80.1 105 29.9 26 71.4 140 28.6 56     
Don’t know         4.8 36  
How do you think HPV is             
spread?             




Anal sex 90.0 118 10.0 13 88.2 173 11.8 23    
Oral sex 70.2 92 29.8 39 69.3 136 10.7 60    
Don’t know         5.1 19  
Ways to help prevent the            
spread of HPV            
Abstinence 71.8 94 28.2 37 77.6 152 22.4 44   P<0.05 
Proper condom use 85.5 112 14.5 19 82.7 162 17.3 34    
Don’t know         7.8 29  
Which of the following            
increases your risk for            
HPV infection            
Sex before the age of 18 77.0 101 23.0 30 73.0 143 27.0 53   P<0.05 
You have many sexual            
partners 86.0 113 13.0 12 85.0 166 15.0 30    
Your partner has many            
sexual partners 88.5 116 11.5 15 82.7 162 17.3 34    
Excessive stress 44.0 58 56.0 73 50.0 98 50.0 98    
Poor nutrition 32.0 43 68.0 88 38.8 76 61.2 120    
Smoking 15.0 20 85.0 111 20.0 39 80.0 157    
Don’t know         6.4 24  
Have you ever heard of            
GardasilTM, a vaccine to            
prevent cervical cancer            
that was approved by the            
FDA in June 2006?            
Yes 66.0 86 34.0 45 70.0 138 30.0 58   P<0.05 
No 30.0 90 68.2 25 65.0 127 35.0 67    






The results show that 85.6% female respondents and 83.2% male respondents had heard 
of HPV. There were 70% of the female respondents and only 66% of the male respondents that had 
heard about the HPV vaccination. When asked if they believed that warts that sometimes itch or 
bleed are a symptom of HPV, 68% of the male respondents agreed and only 60.3% of the female 
respondents agreed. However, when asked if abstinence was a way to prevent the spread of HPV, 
77.6% of the female respondents agreed and only 70.1% of the male respondents agreed. 
 
Mean knowledge scores were also calculated by gender and an independent t-test was 
run to determine if there was a statistically significant difference between genders on the 





Mean averages of HPV knowledge question responses by gender - test of significance by gender 
_______________________________________________________________________________ 
Variable M SD t df p 
_______________________________________________________________________________  
Knowledge about  0.577 316 .564 
HPV vaccination     
Males 47.1679 13.78525   




Table 4.6 shows that there was no statistical difference between male and female students 
on their knowledge about HPV (p = .564). Closer inspection of the two group’s means indicates 
 
that the male students (x̅ =47.1679) scored lower than the female students on their knowledge of 
HPV (x̅ = 48.1230). Results indicate that knowledge about HPV was low for both male and female 
university students. This is especially troubling as HPV is the main risk factor for reproductive 
organ cancers in both men and women. 
 
In comparison to the female respondents, the knowledge deficit for males was slightly 
higher regarding the importance of both genders receiving the vaccination. The results of the study 
indicate that both males and females had little or no knowledge about the male role in the spread of 
HPV infections (see Table 4. 13). 
 
Research Question 2 
 
Is there a difference in attitude between males and females toward obtaining the HPV vaccine? 
The second construct of the Theory of Planned Behavior examines how attitudes/beliefs 
 
influence behavior. In the current study, how attitudes/beliefs about HPV and the HPV vaccine 
were examined. Respondents were asked 12 Likert-scale questions, coded as 5 for strongly agree, 
4 as agree, 3 as not sure, 2 as disagree and 1 as strongly disagree. A mean score closer to five 
would indicate positive attitudes/beliefs about the HPV vaccine as protection against the virus 
and/or subsequent development of cancer. Table 4.7 reports the mean scores on attitudes and 





Mean Scores and Standard Deviation on Attitudes toward obtaining the HPV vaccine 
___________________________________________________________________________ 
Males Females 




HPV shot not safe 2.68 1.069 2.02 1.076 
HPV vaccines give one the disease 2.71 1.078 2.35 1.057 
HPV shot protects males’ health 3.51 1.098 3.87 1.022 
Vaccine protects against oral cancer 3.01 .916 2.87 .770 
Vaccine protects against anal cancer 2.96 .854 2.93 .832 
Vaccine protects against genital warts 3.17 .876 3.04 .890 
Vaccine protects sexual partners 3.47 1.077 3.53 1.057 
Asking for vaccine would be embarrassing 2.54 1.307 1.88 1.075 
Getting infected with HPV concerns me 3.13 1.234 3.44 1.326 
Worried about HPV causing cancer 3.58 1.243 3.44 1.326 
Worry about spreading to someone 2.97 1.559 2.46 1.454 
HPV responsibility of women 2.53 1.338 2.04 1.183 
 
 
For the attitudes and beliefs about HPV mean scores ranged from x̅ =2.54-3.58 for males 
and x̅=2.02-3.53. The lowest mean score for males was x̅= 2.53 for the statement “HPV is the 
responsibility of women” indicating that male students were not sure that this should be true. For 
 
the female students the lowest mean score was x̅=1.88 was for the statement “Asking for vaccine 
 
would be embarrassing,” indicating their disagreement that they would be embarrassed to ask for 
 
the vaccine.  The mean scores for the set of questions assessing attitude/beliefs about obtaining the 
 
HPV vaccine indicated very unsure attitudes/beliefs for both males and females about the 
 
protectiveness of the HPV vaccine to prevent HPV infection and cancer development.  An 
 
independent t-test was run to determine if statistically significant gender differences existed for 
 
mean scores on attitudes/beliefs about obtaining the HPV vaccine. Table 4.8 shows that male 
 
students differed significantly from female students on their attitudes/beliefs about obtaining the 
 






Table 4.8  
Means Scores and Standard Deviation of attitude responses concerning HPV vaccination 
by gender-test of significance by gender 
_______________________________________________________________________________  
Variable M SD t df p 
_______________________________________________________________________________ 
Attitude about  4.681 308 .000* 
HPV vaccination    
Males 3.1880 .51304   




Research Question 3 
 
Is there a difference in the influence of others between males and females toward obtaining 
the HPV vaccine?  
The influence of others, the subjective norms construct of the Theory of Planned 
Behavior, examines how important people in a person’s environment may influence decisions 
about behavior (the world around them, friends, family, peer group behavior), specific to this study, 
the decision to obtain the HPV vaccine. This construct was assessed by five questions from a five-
point Likert scale. Responses were coded as 5 for strongly agree, 4 as agree, 3 as not sure, 2 as 
disagree and 1 as strongly disagree. A mean score closer to 5 would indicate that the individual 
would be more likely to be influenced by subjective norms in their decision to receive the HPV 
vaccination. Mean scores for each item were calculated for both male and females and are 
presented in Table 4.9. 
 
Means scores for all items in this subscale yielded mixed results. Mean scores ranged 
from x̅ = 2.66-3.41 for males and x̅ =2.36-4.05 for females, closer to being influenced by 
people rather than social pressure; with female students agreeing that their doctor would 
support them getting the vaccine. 
 
Table 4.9  
Means Scores and Standard Deviation of Influence of others as a barrier to HPV vaccination 
by gender  
Males Females 
 








Important people want shot for me 3.14 1.043 3.54 1.127 
It is expected that I get shot 3.13 1.119 3.51 1.164 
I am under social pressure to get shot 2.66 1.161 2.36 1.115 
My doctor would support getting shot 3.41 1.159 4.05 1.054 
People like me are getting shot 2.98 0.818 3.46 1.016 
 
 
The mean scores for female students were higher than for male students on all response 
 
items on this subscale, except for the item “I am under social pressure to get the shot”. A test of the 
 
overall means for the scale found a significant difference between male and female students on 
 
their influences toward receiving the HPV vaccination (p =0.000).  This suggests that males were 
 
less likely to be influenced by people close to them compared to females to obtain the HPV 
 
vaccination. The results are presented in Table 4.10. 
 
Table 4.10  
Means Scores and Standard Deviation of the influence of others in obtaining the HPV vaccination 
test of significance by gender  
_______________________________________________________________________________  
Variable M SD t df p  
_______________________________________________________________________________  
Influence toward  3.798 323 0.000* 
HPV vaccination     
Males 3.0615 .66068   
Females 3.3856 .75614    
______________________________________________________________________________  
*p<0.05  
Research question 4 
 
Is there a difference between males and females on their perceived behavioral control to 
obtain the HPV vaccine?  
In the Theory of Planned Behavior attitude toward behavior, subjective norms, and 
 
perceived behavioral control, shape an individual's behavioral intentions that lead to a behavior. 
 
The final construct that was assessed prior to examining overall intention to obtain the HPV 
 
vaccine, was Perceived Behavioral Control.  Perceived behavioral control measured a person’s 
 




For this study, the construct Perceived Behavioral Control was measured by four items: 
 
“Can get shot if want to”; “Confident that I can get shot”; “Vaccination beyond my control”; 
 
“Getting shot is up to me”; and “It would be easy to get shot”. The mean scores for these items are 
 
presented in Table 4.11. 
 
Table 4.11  
Mean scores and Standard Deviation on Perceived Behavioral Control to receive the HPV vaccine  
Males Females 
 
Variable M SD M SD  
___________________________________________________________________________ 
 
Can get shot if want to 3.62 1.255 4.29 .947 
Confident that I can get shot 3.56 1.216 4.29 .958 
Vaccination beyond my control 2.50 1.218 1.95 1.049 
Getting shot is up to me 3.55 1.377 4.17 1.039 
It would be easy to get shot 3.55 .854 4.28 .950 
 
 
Table 4.12 shows that male students (x̅=3.04) were significantly different from female students 
 
(x̅=3.8) on their overall perception of behavioral control for obtaining the HPV vaccine (p=0.000). 
 
Inspection of the two groups indicates that perceived behavioral control is a strong indicator of 
 
whether an individual will be vaccinated or not. 
 
 
Table 4.12  
Mean scores of perceived behavioral control responses concerning HPV vaccination by gender-
test of significance by gender 
_______________________________________________________________________________  
Variable M SD t df p 
_______________________________________________________________________________ 
Perceived Behavioral Control 5.712 324 0.000* 
HPV vaccination     
Males 3.3557 .81043   
Perceived Behavioral Control 5.712 324 0.000* 
HPV vaccination     







The final analysis performed was a binomial logistic regression to create a prediction 
model that included the knowledge, attitude/beliefs, influences on behavior (subjective norms) and 
perceived behavioral control on intention to receive the HPV vaccine. The question “The 
information you have about the vaccine has caused you to” was recoded from 6 responses to 2 
where the first response “be vaccinated” was the reference. The analysis for logistic regression did 
not differentiate between participants who were not vaccinated and those who had received at least 
one shot in the series. The results of the logistic regression are presented in Table 4.13. 
 
Research Question 5 
 
Is there a difference between males and females in intention to obtain the HPV vaccine? 
 
Table 4.13 




Predictor B SEB ß 
Female    
Attitude 1.775 0.183 1.040 
Influences 5.492 0.003 1.356* 
Perceived behavioral control 3.127 0.010 2.834  
Male    
Attitude 2.101 0.147 1.059 
Influences 3.063 0.070 2.119 
Perceived Behavioral Control 2.205 0.007 1.930* 
_____________________________________________________________________________ 
Note. R2  = .52: F(186,131) = 12.23 
*p<0.05 **p<0.01 ***p<0.001 
 
The logistic regression was performed to ascertain the effects of gender, attitudes, 
influences, and perceived behavioral control on the likelihood that participants intend to obtain the 
HPV vaccine. The analysis did not differentiate whether participants had been vaccinated or not. 
The logistic regression model was statistically significant for the construct scores of perceived 
behavioral control and influences on intention to obtain the HPV vaccine. The results found that 
females in the study had a 2.834 times higher perception of their ability to obtain the HPV 




vaccine, male respondents were 2.119 times more likely to be influenced by family or friends 
compared to female respondents, suggesting that the males believe that people who are 
important to them would want them to receive the vaccination. 
 
Logistic regression determines the likelihood value or predicted probability of getting a 
desired result, therefore, the data suggests that attitudes were not a strong predictor for HPV 
vaccination among the participants. However, the data does suggest that gender, perceived 
behavioral control and influence of others were predictors for the participants’ intentions to 
receive the HPV vaccination. These findings are consistent with the overall means scores for 
perceived behavioral control in that male participants (x̅=3.04) scored significantly lower than 
female participants (x̅=3.8) in the study. 
Summary 
 
The results of the study were presented in this chapter. Overall results indicate that males 
are less knowledgeable than females on specific facts about the HPV virus and the vaccination. 
Both male and female students had little knowledge about the role of males in the spread of HPV. 
Embarrassment about asking a physician about the vaccination was listed as a factor in obtaining 
the vaccination for both males and females. Male participants scored significantly lower than the 
score for female participants when asked if they are influenced by family or peers to receive the 
HPV vaccination, indicating that males are not being influenced by significant others to get 
vaccinated. Finally, the results show that male students were significantly different from female 










The purpose of this study was to assess the attitudes toward the HPV vaccination and its 
influence to serve as a barrier to HPV vaccine acquisition among a sample of rural university 
students. Specifically, this study investigated whether knowledge about HPV, attitude toward 
HPV, the influence of others, and perceived behavioral control predicted the intention to receive 
HPV vaccination and whether the pattern of these influences differed by gender. The subjects for 
the study were 383 matriculated students, enrolled at a university in Southeast Georgia. This 
chapter contains the summary and discussion of the quantitative results as they relate to existing 
literature, the conclusions of the study, the limitations of the study, implications for community-
based public health practice and recommendations for future study on how HPV vaccination 
uptake is influenced. 
 
Summary and Discussion 
 
The current study utilized the Theory of Planned Behavior as a framework for data 
analysis and understanding of college aged students’ knowledge, attitudes, influences of others, and 
perceived behavioral control about HPV, and the intention to be vaccinated to prevent 
 
HPV. Overall, males were less knowledgeable about HPV including risk factors, treatment, and 
prevention compared to females. This is similar to results found in a study by Stanley (2017) in 
which it was found that while most of the men in the study envisioned an ideology that men and 
women share equal knowledge about sexual health, realistically, most of the men agreed that 
women have better access to knowledge about sexual health through their mothers . The study also 
found that men believed that their fathers felt too much discomfort to discuss sensitive sexual 
material with their sons. Because there is a discrepancy in the parental knowledge afforded to sons 
and daughters about sexual health, there is a significant knowledge deficit for males concerning 




The results of the study indicate that a higher percentage of males had also not heard 
of Gardasil. One reason that might explain this is that advertisements and recommendations 
from health care providers were until recently were targeted towards young women. This result 
is consistent with another study in which respondents were asked about Gardasil (Gilbert, 2010). 
Even before the HPV vaccination Gardasil was approved, Merck Pharmaceuticals touted the 
vaccine as a women’s only health issue through their awareness campaigns that linked the 
vaccine’s effectiveness in decreasing incidence of cervical cancer, though research has proven a 
positive link in the transmission of HPV to both men and women. 
 
The study demonstrated that male and female university students have different 
perceptions about the role they play in acquiring HPV and preventing the spread. More female than 
male students strongly agreed that HPV prevention should be the responsibility of women. The 
results of the current study are similar to findings from a study performed by Ott (2010) in which it 
was posited that the cultural norms and attitudes toward males’ perception of sexual health can 
stem from interpersonal relationships. Cultural views of masculinity and gender roles about sexual 
health are well defined by the time men enter college (Ott, 2010). In another study, it was 
hypothesized that most of the male participants in the study would report that they had not heard of 
Gardasil as a vaccination for the prevention of HPV and related cancers for men. As expected, 
most of the male participants indicated that they were unaware of the male role in the spread of 
HPV and were unaware of a vaccination for the prevention of HPV (Gilbert, 2010). In the study 
performed by Catalano (2017), insufficient knowledge about HPV was directly correlated with low 
vaccination rates among males (Catalano, et.al, 2017). 
 
Attitudes/Beliefs toward HPV and HPV vaccine 
 
Overall, attitudes and beliefs about HPV and obtaining the vaccine among the males in the 
study showed that they had more negative attitudes and beliefs about HPV vaccination uptake. 
Because the Theory of Planned behavior posits that the key component to the model is behavioral 




behavior will have the expected outcome, this finding is significant in determining why male 
vaccination rates for HPV are low (Thompson, et.al., 2016). 
 
The current study suggests that attitudes toward HPV vaccination and the ability to 
perform them were strong predictors of whether male students would be vaccinated. The findings 
are consistent with a study performed by Gilbert (2010) in which the contextual development 
about sexual issues for males, as well as sexual health, were studied in familial and institutional 
environments to gain a better understanding about their relationship to HPV vaccine uptake among 
males (Gilbert, 2010). Gilbert’s study suggested that perception of the “feminization” of sexual 
issues dictates the male role in responsibility toward sexual health and prevention measures, 
including HPV vaccine uptake. 
 
The Theory of Planned Behavior also asserts that subjective norms, or what an 
individual is exposed to socially or familiarly, has a considerable impact on his or her intention to 
perform a behavior. The mean scores for female students were higher than for male students on all 
response items about the influence of others to receive the HPV vaccine except for the item “I am 
under social pressure to get the shot.” This is consistent with a study by Stanley which asserts that 
because men have consistently not been the target of ad campaigns for HPV prevention, perceived 
norms for male vaccination may not be established yet (Stanley, 2017). 
 
Perceived Behavioral Control 
 
Perceived Behavior Control, or the belief that an individual can perform a certain 
behavior, was a weak predictor of intention to obtain the vaccine. Because the data in the current 
study is consistent with results in the study by Catalano, et.al., (2017) finding that perceived 
behavioral control adds only slightly to the overall predictive power of the TPB and HPV 
vaccination, suggesting that attitudes, knowledge, and influence may be more important predictors 
for HPV vaccination. In the study by Catalano et.al., (2017) it was suggested that because 
respondents lacked enough knowledge about HPV and the HPV vaccination process, they would 




(Catalano, et. al., 2017). Inadequate knowledge about HPV and HPV vaccination was also a 
factor in low means scores for behavioral intention to receive the HPV vaccination for both male 
and female respondents in the current study. 
 
Because the initial approach by Merck Pharmaceuticals for the HPV vaccination was 
focused on attaining higher vaccination rates among females, males have been at a disadvantage in 
gaining the knowledge and awareness necessary to achieve perceived ability to receive the HPV 
vaccination within the context of perceived barriers. 
 
Intention to Obtain the HPV Vaccination 
 
Although most men had heard of HPV, they knew relatively little about the HPV 
vaccination, the risks for infection, and their role in the spread of HPV. The results are consistent 
with the study by Johnson and Ogletree (2017) in that perceived knowledge about HPV vaccination 
may be part of the males’ belief systems, which would motivate them in their intention to receive 
the vaccination. The females in the in the study scored slightly higher for both knowledge about 
HPV and the HPV vaccination. However, because the HPV vaccine was initially approved for and 
marketed to women by Merck Pharmaceuticals, it is not surprising that the females in the study 
knew more about it than the males did. 
 
Among the female respondents who had not received the vaccine (N= 79), most of them 
reported greater perceived behavioral control in their intention to one day be vaccinated. Although 
most of the men believed that they could get the vaccination if they wanted to, the majority of the 
males in the study indicated that they had not heard of Gardasil prior to the current study, 
suggesting that there are still significant gaps in the marketing of Gardasil for men that need to be 
addressed. These findings are similar to the study by Catatlano, et. al., (2017), in that most of the 
males in their study had heard HPV but 60% of the respondents indicated that they had not heard of 






Limitations were taken into consideration when presenting the findings from the study. 
Attempts were made to recruit a diverse sample by using random sampling. Since the instrument 
was administered as a self-reported questionnaire, information collected may not be accurate. 
The questions in the survey may have been a limitation in that they have predetermined response 
categories, thus limiting the range of responses. Because the HPV vaccine has been approved for 
young men and women ages 9 to 26, another limitation of the study could be that only college 
students ages 18 to 26 are being examined. Efficacy of vaccine uptake in future trials should be 
performed with a larger cohort, with a more diverse age group in the sample. 
 
The sample size for qualitative studies was small and the findings necessary for this in-
depth exploratory research study was limited and may have confounded the data because 
qualitative research tends to have less statistical power than quantitative research when it comes to 
verifying trends. Although the quantitative analysis minimized confounding, a quantitative 
approach for research analysis is limited in providing an adequate explanation for social or cultural 
phenomena. The utilization of a mixed-method study may have potentially counterbalanced the 
weaknesses of the study, however time constraints were a factor as well, because data was only 
collected in classes during times that were approved by the instructor. 
 
Recommendations for Future Studies 
 
Because HPV is commonly thought of as a women’s health issue, males are at a 
 
disadvantage concerning accurate information given to them about HPV and HPV vaccinations 
 
from peers, family members and the media. A multi-level approach, such as utilizing the Social 
 
Ecological Model (SEM), can assist researchers in determining the personal and environmental 
 
factors that influence behaviors; in this case, what factors determine whether males will be 
 
vaccinated against HPV or not. At the individual level, researchers can look at male participants’ 
 
level of education, socioeconomic status, or their lack of knowledge about the HPV vaccination 
 




assessed, as well as cultural or religious influences about sexual issues. The organizational, community 
and policy levels of the SEM can be studied by researching the lack of communication and education 
concerning HPV vaccination in neighborhoods, schools and workplaces. 
 
The lack of dissemination of information about the importance of receiving the HPV 
vaccine from healthcare providers to male patients is wholly under-researched. Interventions to 
stress the importance of healthcare providers acknowledging the HPV vaccination as genderless 
is imperative to increase male vaccine uptake. 
 
To achieve more in-depth and robust findings, future studies should employ a mixed 
methods approach. Because research about barriers to male HPV vaccination is wholly under-
researched, adding a qualitative piece would allow researchers gains in breadth and depth of an 
understanding of this phenomenon, while offsetting the weaknesses inherent to using a 
quantitative approach by itself. 
 
To get a more definitive result from logistic regression analysis for perceived 
behavioral control, future researchers should differentiate between participants who have never 
received the HPV vaccination and those who have had at least one shot in the series. 
 
Implications for Public Health Practice 
 
The current findings have several important implications for public health education to 
promote HPV vaccine uptake and the prevention of HPV-related cancers among men and women. 
It appears that knowledge about HPV and HPV prevention is a strong predictor of HPV vaccination 
among males. This finding provides opportunities for public health programs in that they can be 
designed specifically to increase knowledge and awareness among males about HPV acquisition 
and their role in the spread of the disease. A partnership could be formed with the university and 
local health departments to implement HPV and HPV vaccination programs; particularly among 
male students. 
 
Strong familial and social support for HPV vaccination influence both females’ and 




males, it is imperative that ad campaigns continue to target parents of adolescents. Based on the 
findings from this study, it is clear that public health programs are necessary to educate men about 
the importance of receiving the HPV vaccination and the efficaciousness of the HPV vaccination. 
Without HPV vaccination programs to educate males about the severity of HPV related cancers 
specific to men, rates for male vaccination uptake continue to be significantly lower than those for 
women. 
 
Because it was concluded from this study that social norms (family and friends) from 
specific sources is a strong indicator for men’s intentions to receive the HPV vaccination, 
public health educators can develop programs that prioritize broad social support to enhance 
male vaccination uptake, including forming social support networks consisting of physicians, 
family, friends and peers. 
 
The economic burden associated with non-cervical HPV-related cancers occurring in 
individuals living in the United States was approximately $418 million in 2014. It would be 
financially advantageous for the United States to implement programs promoting the use of 9vHPV 
vaccines to protect males against contracting oncogenic HPV types to decrease morbidity and 
mortality rates due to HPV related cancers. Practitioners, universities and Health Departments can 
provide basic information about HPV to the public that includes information about the route of 
transmission, prevalence of HPV-related cancers among men and women and the safety and 
efficaciousness of the vaccine as protection against HPV acquisition. 
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 APPENDIX A 
KNOWLEDGE AND ATTITUDES TOWARD THE HUMAN 
PAPILLOMAVIRUS (HPV) VACCINE AMONG COLLEGE STUDENTS 
My name is Kristina Harbaugh and I am a doctoral student at Georgia Southern University Jiann-Ping 
Hsu College of Public Health. You are invited to participate in a research study that is assessing the 
knowledge about and attitudes toward the Human Papillomavirus (HPV) vaccine. Results from the 
study will be used to develop strategies to increase the participation rate among males in obtaining 
the HPV vaccine as a cancer prevention measure. Please DO NOT write your name or any other 
identifying information anywhere on the questionnaire. Responses will be kept confidential and will 
only be seen by myself and the dissertation committee. Your participation is voluntary. Completing 
the survey in its entirety indicates consent to participate. You may choose to withdraw from 
completing the survey or to not answer a specific question. Thank you for your help in learning more 
about the knowledge, attitudes and intention to obtain HPV vaccine. This project has been reviewed 
and approved by the GSU Institutional Review Board under tracking number H18352. For questions 
concerning your rights as a research participant, contact Georgia Southern University Office of 
Research Services and Sponsored Programs at 912-478-5465. 
Section I: In this section, you are being asked about your knowledge about the 
Human Papillomavirus (HPV). Please check all that apply 




________Health education program (i.e. at school or business) 
________Magazine, newspaper, or another periodical 
________Radio or TV 
________Have never heard of HPV (Human papillomavirus) until today 
2. If you have ever heard of HPV, the symptoms of HPV include: (Please check all that apply)
_______Warts that sometime itch or bleed
_______Sores of penis or vagina that don’t heal.





_______Burning upon urination 
_______Reduction of urine flow 
_______No visible signs or symptoms 
_______Don’t know 
 
3. If untreated, HPV can: (Please check all that apply). 
 
_______Cause cervical cancer _______Can cause warts _______Cause 
infertility _______Will usually disappear by itself _______Can cause pre-
cancer _______Can cause sterility _______Can cause death 
________Don’t know 
 
4. How do you think HPV is spread? (Please check all that apply).  
_______Vaginal sex _______Kissing 
_______Anal sex _______Coughing 
_______Oral sex _______Toilet seat 
_______Casual contact (Hug, handshake) _______Don’t know 
 
5. HPV is more likely to be spread by the: (Please check one). 
_______Male 
_______Female 
_______Male or female 
_______Don’t know 
 





7. Ways to help prevent the spread of HPV are: (Please check all that apply).  
_______Abstinence _______Douching 
_______Proper condom usage _______Withdrawal of penis before ejaculation 
_______Washing after sex _______Don’t know 
 
8. Which of the following increases your risk for HPV infection (Please check all that apply).  
_______Sex before the age of sixteen _______Birth control pills 
_______You have many sexual partners _______Smoking 
_______Your partner has had many sexual partners 
_______Excessive stress   
_______Poor nutrition   
_______Don’t know   
9. HPV is mainly a disease of (Please check one). 
_______Male homosexuals _______Females 
_______Female homosexuals _______Males 
_______Bisexual individuals _______Anyone having sexual contact 
_______Heterosexuals _______Don’t know 
 
10. Have you ever heard of Gardasil™, a vaccine to prevent cervical cancer that was approved by 








11. Have you ever been vaccinated against HPV? 
_______Yes, I received all three dosages of the vaccine 
_______No, I either never received any dosage OR I received partial dosage (1 of 3 or 2 of 3) 
_______Not Sure 
 
For Sections II through IV, choose the level of agreement that best matches your 
beliefs, attitudes, or opinion 
 
Section II: The following questions assess your attitude & beliefs toward the HPV vaccine. 
Select ONE answer for each item below: 
 
 Strongly Agree Not Disagree Strongly 
 Agree  Sure  Disagree 
      
12. It is not      
safe to get      
the HPV      
vaccine      
shots.      
13. You can      
get infected      
with HPV      
from HPV      
vaccine      
shots.      
14. Getting      
vaccine shots      
against HPV      
would be a      
good way for      
males to      
protect their      
health.      
15. The      
vaccine      
would      
protect me      
against oral      
cancer.      
16. The HPV      
vaccine      
would      
protect me      
against anal      
cancer.      
17. The HPV      
vaccine      







genital warts.  




























HPV if it 
could cause 
cancer.  
22. If I had 
HPV I would 
worry about 
spreading it 
to my partner 





23. HPV  
prevention 
should be the 
responsibility 
of women  
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Section III: The following questions assess the degree to which I value other people’s 
opinions concerning the HPV vaccination. Select ONE answer for each item below: 
Strongly Agree Not Disagree Strongly 












































Section IV: The following questions assess the degree to which you would intend to obtain the 
HPV vaccination. Select ONE answer for each item below: 
Strongly Agree Not Disagree Strongly 






































Section V: Please select all that apply. 
34. From which of the following sources have you ever received information about Gardasil™?



















_______Do not think it is important 
_______Do not think you are at risk 
_______Need more information  









37. The information you have about the vaccine has caused you to: (Check all that apply)  
_______Be vaccinated 
_______Speak to your physician or other health professional about the vaccine 
_______Share your knowledge with family or friends  
_______Do further research on your own about the vaccine and the link 
between cervical cancer and HPV  
_______Visit Merck’s website 
_______I have no information about the vaccine 
 





_______Don’t know/not sure 
 
Section VI: Background Information  
This set of questions tells us a little more about who is completing the questionnaire. 
Please check only one answer for each question. 




40. What is your race? 
________ White/Caucasian 
________ Black or African American 





________ Native Hawaiian or Pacific Islander 
________ Two or more races 
________ Other 
 
41. In which college are you enrolled? 
_______Jiann-Ping Hsu College of Public Health (COPH) 
_______College of Business Administration (COBA)  
_______College of Behavioral and Social Sciences (CBSS) 
_______College of Arts and Humanities (CAH) 
_______Don & Cindy Waters College of Health Professions (DCWCHP) 
_______College of Education (COE) 
_______College of Science and Mathematics (COSM)  
_______Other________________ 
 










44. Please mark the category that includes the age at which you first had sexual intercourse. 
________ (11-12) ________ (19-22) 
________ (13-15) ________ (23+) 
________ (16-18) 
 
45. How many sexual partners have you had in your lifetime?  ______ 
 
46. How often do you wear a condom when you are having sexual intercourse? 
________ Every time 
________ Most of the time 
________ Sometimes 
________ Hardly ever 
________ Never 
 
47. What is your current relationship status?  
________ Single 
________ Dating  
________ Monogamous relationship 
________ Married and living with partner 
________ Not married but living with a partner 
________ Divorced 
 
48. In general, would you say your health is: 
________ Excellent 
________ Very Good 







THANK YOU!  
In order to gain a more in-depth understanding of attitudes toward both HPV and the vaccine to 
prevent long-term health consequences, you are invited to participate in a compensated personal 
interview. If you are interested, please contact the principal investigator, Kristina Harbaugh in 
















































FREQUENCY STATISTICS OF KNOWLEDGE, AWARENESS, SYMPTOMS, SPREAD, 
RISK AND CAUSES OF HPV AMONG FEMALE COLLEGE STUDENTS 
Variables Frequenc Percentag Missin 
y (n) e (%) g 
Heard of 56 
HPV 
Doctor 35 17.9 
Friends or 51 26.0 
Acquaintance 
Health 50 25.5 
Education 
Program 




Radio or TV 22 11.2 
Haver never 1 .5 
heard of HPV 
until today 
Symptom 1 




Warts that 28 14.3 
itch or bleed   
Sores of penis 23 11.7 
or vagina that   
do not heal   
Discharge 17 8.7 
from genitals   
Warty 23 11.7 
growths   
Burning upon 7 3.6 
urination   
Reduction of 1 .5 
urine flow   
No visible 9 4.6 
signs or   
symptoms   
Don’t know 88 44.9 
Untreated  1 
HPV can   
cause   
Cervical 26 13.3 
cancer   
Infertility 34 17.3 
Pre-cancer 28 14.3 
Death 20 10.2 
77 
Warts 20 10.2 
Disappears by 18 9.2 
itself 
Sterility 1 .5 
Don’t know 48 24.5 
HPV is 2 
spread by 
Vaginal sex 32 19.4 
Anal sex 38 25.5 
Oral sex 48 36.7 





Male 1 .5 
Female 7 3.6 
Male or 74 37.8 
female 












True 91 46.4 
False 6 3.1 
Don’t know 98 50.0 
Ways to  10 
prevent   
spread of   
HPV   
Abstinence 50 25.5 
Proper 91 46.4 
condom use   
Don’t know 43 21.9 
What  1 
increases   
risk for   
HPV   
infection   
Sex before 6 3.1 
age of sixteen   
Many sexual 86 43.9 
partners   
Partner has 50 25.5 
many sexual   
partners   
Excessive 5 2.6 




Poor nutrition 5 2.6 
Birth control 4 2.0 
pills   
Smoking   
Don’t know 39 19.9 
HPV  1 
mainly a   
disease of   
Anyone 91 46.4 
having sexual   
contact   
Don’t know 104 53.1 
Heard of   
Gardasil   
Yes 133 67.9 
No 41 20.9 
Not sure 20 10.2 
Ever been  1 
vaccinate   
d against   
HPV   
Yes 115 58.7 






















































FREQUENCY STATISTICS OF KNOWLEDGE OF AWARENESS, SYMPTOMS, SPREAD, 
RISK AND CAUSES OF HPV AMONG MALE COLLEGE STUDENTS 
Variables Frequency Percentage   Missing 
(n) (%) 
Heard of HPV 26 
Doctor 34 26.0 
Friends or Acquaintances 33 25.2 
Health Education Program 34 26.0 
Magazine, Newspaper or other 15 11.5 
Periodical 
Radio or TV 14 10.7 
Haver never heard of HPV until 1 .8 
today 




Warts that itch or bleed 10 7.6 
Sores of penis or vagina that do not 13 9.9 
heal   
Discharge from genitals 19 14.5 
Warty growths 18 13.7 
Burning upon urination 7 5.3 
Reduction of urine flow 4 3.1 
No visible signs or symptoms 5 3.8 
Don’t know 54 41.2 
Untreated HPV can cause  1 
Cervical cancer 13 9.9 
Infertility 21 16.0 
Pre-cancer 19 14.5 
Death 16 12.2 
Warts 11 8.4 
83 
Disappears by itself 5 3.8 
Sterility 1 .8 
Don’t know 44 33.6 
HPV is spread by 3 
Vaginal sex 22 16.8 
Anal sex 31 23.7 
Oral sex 44 24.4 
Don’t know 31 23.7 
HPV more likely spread by 1 
Male 51 38.9 
Female 4 3.1 
Male or female 12 9.2 
Don’t know 63 48.1 
HPV passed from mother to 4 
child during birth 
True 61 46.6 
83 
False 4 3.1 
Don’t know 62 47.3 
Ways to prevent spread of 12 
HPV 
Abstinence 25 19.1 
Proper condom use 53 40.5 
Don’t know 38 29.0 
What increases risk for HPV 1 
infection 
Sex before age of sixteen 4 3.1 
Many sexual partners 64 48.9 
Partner has many sexual partners 26 19.8 
Excessive stress 5 3.8 
Poor nutrition 
Birth control pills 
Smoking 1 .8 
84 
Don’t know 30 22.9 
HPV mainly a disease of 1 
Anyone having sexual contact 55 42.0 
Don’t know 75 57.3 
Heard of Gardasil 4 
Yes 41 31.3 
No 60 45.8 
Not sure 26 19.8 
Ever been vaccinated against 9 
HPV 
Yes 37 28.2 
No 34 26.0 






FREQUENCY STATISTICS OF FEMALE COLLEGE STUDENTS’ ATTITUDES AND BELIEFS 
TOWARD OBTAINING THE HPV VACCINE 
  
Variable Frequency Percentage   Missing 
 (n) (%) 
   





Strongly 80 40.8 
disagree   
Disagree 56 28.6 
Not sure 43 21.9 
Agree 10 5.1 
Strongly 7 3.6 
agree   






Strongly 53 27 
disagree   
Disagree 47 24 
 
 
Not sure 74 37.8 
86 
Agree 15 7.7 
Strongly 6 3.1 
agree 
Getting vaccine shots against HPV would be a good way 0 
for males to protect their health. 
Strongly 61 31.1 
disagree 
Disagree 73 37.2 
Not sure 44 22.4 
Agree 12 6.1 
Strongly 6 3.1 
agree 
The vaccine would protect me against oral cancer. 2 
Strongly 7 3.6 
disagree 
Disagree 16 8.2 
Not sure 124 63.3 




Strongly 9 4.6 
agree   
The HPV vaccine would protect me against anal cancer.  1 
Strongly 11 5.6 
disagree   
Disagree 18 9.2 
Not sure 123 62.8 
Agree 33 16.8 
Strongly 10 5.1 
agree   
The HPV vaccine would protect me against genital  2 
warts.   
Strongly 15 7.7 
disagree   
Disagree 29 14.8 
Not sure 104 53.1 
Agree 40 20.4 
Strongly 6 3.1 




Getting the HPV vaccine would protect sexual partner(s)  1 
against HPV infection.   
Strongly 36 18.4 
disagree   
Disagree 72 36.7 
Not sure 53 27.0 
Agree 27 13.8 
Strongly 7 3.6 
agree   
Asking for the HPV vaccine would be embarrassing for  1 
me   
Strongly 91 46.4 
disagree   
Disagree 63 32.1 
Not sure 21 10.7 
Agree 13 6.6 
Strongly 7 3.6 
agree   
The possibility of getting infected with HPV concerns  3 




Strongly 49 25.0 
disagree   
Disagree 61 31.1 
Not sure 31 15.8 
Agree 30 15.3 
Strongly 22 11.2 
agree   
I would be more worried about contracting or spreading  1 






Strongly 13 6.6 
disagree   
Disagree 31 15.8 
Not sure 37 18.9 
Agree 58 29.6 
Strongly 56 28.6 
agree   
If I had HPV I would worry about spreading it to my  1 
partner only if my partner is someone I really care   






Strongly 67 34.2 
disagree   
         90 
 
 
Disagree 54 27.6 
Not sure 24 12.2 
Agree 18 9.2 
Strongly 30 16.3 
agree   






Strongly 88 44.9 
disagree   
Disagree 46 23.5 
Not sure 35 17.9 
Agree 17 8.7 
Strongly 9 4.6 
agree   




















FREQUENCY STATISTICS OF MALE COLLEGE STUDENTS’ ATTITUDES AND BELIEFS 
TOWARD OBTAINING THE HPV VACCINE 





It is not safe to get the HPV vaccine       0 
  Strongly 
disagree 
21 16.0   
  Disagree 29 22.1   
  Not sure 62 47.3   
  Agree 9 6.9   
  Strongly 
agree 
10 7.6   
You can get infected with HPV from HPV vaccine 
shots 
      0 
  Strongly 
disagree 
23 17.6   
  Disagree 23 17.6   
  Not sure 62 47.3   
  Agree 15 11.5   
  Strongly 
agree 
8 6.1   
Getting vaccine shots against HPV would be a good 
way for males to protect their health. 




Disagree 51 38.9 
Not sure 42 32.1 








Disagree 10 7.6 
Not sure 85 64.9 




The HPV vaccine would protect me against anal 
cancer. 
0 
  Strongly 
disagree 
9 6.9             93  
  Disagree 9 6.9   
  Not sure 90 68.7   
  Agree 14 10.7   
  Strongly 
agree 
9 6.9   
The HPV vaccine would protect me against genital 
warts. 
      2 
  Strongly 
disagree 
10 7.6   
  Disagree 27 20.6   
  Not sure 72 55.0   
  Agree 15 11.5   
  Strongly 
agree 
5 3.8   
Getting the HPV vaccine would protect sexual 
partner(s) against HPV infection. 
      0 
  Strongly 
disagree 
27 20.6   
  Disagree 34 26.0   
  Not sure 50 38.2 94  
  Agree 14 10.7   
  Strongly 
agree 
6 4.6   
Asking for the HPV vaccine would be embarrassing for 
me 
      1 
  Strongly 
disagree 
35 26.7   
  Disagree 37 28.2   
  Not sure 23 17.6   
  Agree 23 17.6   
  Strongly 
agree 
12 9.2   
The possibility of getting infected with HPV concerns 
me.  
      2 
  Strongly 
disagree 
20 15.3   
  Disagree 33 25.2   
  Not sure 34 26.0   
  Agree 28 21.4   
  Strongly 
agree 
14 10.7   
I would be more worried about contracting or 
spreading HPV if it could cause cancer. 
           95 
  Strongly 
disagree 
21 16.0   
  Disagree 19 14.5   
  Not sure 23 17.6   
  Agree 31 23.7   
  Strongly 
agree 
36 27.5   
If I had HPV I would worry about spreading it to my 
partner only if my partner is someone I really care 
about. 
      0 
  Strongly 
disagree 
36 27.5   
  Disagree 20 15.3   
  Not sure 19 14.5   
  Agree 24 18.3   
  Strongly 
agree 
32 24.4   
HPV prevention should be the responsibility of women       0 
  Strongly 
disagree 
37 28.2  96 
  Disagree 33 25.2   
  Not sure 32 24.4   
  Agree 12 9.2   
  Strongly 
agree 



















































Disagree 10 5.1 
Not sure 13 6.6 
Agree 67 34.2 
Strongly agree 101 51.5 






Disagree 7 3.6 
Not sure 18 9.2 
Agree 62 31.6 
Strongly agree 103 52.6 
Getting vaccinated against HPV is beyond my 
control 
          98 
  Strongly 
disagree 
83 42.3   
  Disagree 62 31.6   
  Not sure 33 16.8   
  Agree 11 5.6   
  Strongly agree 6 3.1   
Whether I get vaccinated against HPV is entirely 
up to me 
      1 
  Strongly 
disagree 
6 3.1   
  Disagree 14 7.1   
  Not sure 13 6.6   
  Agree 70 35.7   
  Strongly agree 92 46.9   
I believe it would be easy for me to get the HPV 
vaccination if I wanted to 
      1 
  Strongly 
disagree 
4 2.0   
Disagree 8 4.1  99 
Not sure 20 10.2 
Agree 61 31.1 
Strongly agree 102 52.0 
